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Abstract 
Most of our knowledge about basic cellular processes has originated from 
model organisms. Saccharomyces cerevisiae is consider a model system, representing 
the simplest eukaryotic organism, whose genome can be easily manipulated allowing 
suitable analysis and efficient assessment of gene products from humans. RAS genes 
encode low molecular weight, GTP-binding, GTP-hydrolysing proteins that are highly 
conserved throughout all eukaryotic species. RAS pathway has attracted attention 
because of its importance in malignant transformation of human cells. KRAS is a 
human RAS isoform, expressed in almost all cell types and essential for the normal 
cellular development, in addition it is the isoform most frequently mutated in many 
cancer types. The S. cerevisiae has two RAS genes, RAS1 and RAS2 that are 
essential, once their double deletion renders yeast unviable. These genes are 
structurally and functionally homolog of the mammalian RAS proto-oncogenes. This 
conservation allows the use of yeast genetics to the study of KRAS. Considering this, 
the first aim of this work was to build a set of S. cerevisiae strains (using haploid 
BY4741 wild type, ras1∆, and ras2∆ as a basis) expressing the human KRASwt cDNA, 
using a plasmid-based expression. The second aim was the phenotype screening of 
these humanized yeasts, as well as of the correspondent recipient strains. The effect of 
KRASwt expression was evaluate on the cell stress response, growth, chronological 
aging, cell cycle progression and haploid invasive growth.  
According to the results, the KRASwt heterologous expression in yeast (1) had a 
negative or null effect on the resistance to the temperature, pH, osmotic and oxidative 
stresses; (2) decreased growth on non-fermentable carbon sources; (3) increased the 
adhesion capacity; (4) stimulated the haploid invasive growth in the ras2∆ strain; (5) 
modified the budding pattern of the wild type cells; (6) changed the cellular proliferation 
in a strain-dependent way; and (7) decreased the chronological lifespan. The results 
indicated that the expression of KRASwt in the wild type strain, possibly leads to a 
hyperactivaction of the RAS/cAMP/PKA signalling pathway, which in turn triggers a 
decrease of stress resistance and longevity. This study also highlighted the relevance 
of the yeast background, to the possible achievement of different results, regardless 
the functional conditions used. The present work contributed to gain insight into KRAS 
mechanism of action using yeast as a model organism. Furthermore, all obtained 
results will constitute part of the development of a yeast-based high throughput 
phenotype platform for future pharmacological testing. 
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Resumo 
Grande parte do nosso conhecimento acerca dos processos celulares 
fundamentais provêm de organismos modelo. A levedura Saccharomyces cerevisiae é 
considerada um sistema modelo, representando um organismo eucariota simples, cujo 
genoma pode ser facilmente manipulado, permitindo uma análise adequada e uma 
avaliação eficiente das proteínas humanas. Os genes RAS codificam proteínas de baixo 
peso molecular, de ligação e hidrólise de GTP, que estão amplamente conservadas em 
todas as espécies eucariótas. O estudo da via RAS tem atraído a atenção devido à sua 
importância na transformação maligna das células humanas. O KRAS é uma das 
isoformas RAS humanas, expressa em quase todos os tipos de células e essencial para o 
normal desenvolvimento celular, para além disso, é também a isoforma que se encontra 
frequentemente mutada em diversos tipos de cancro. S. cerevisiae tem dois genes RAS, 
RAS1 e RAS2, essenciais uma vez que a sua dupla deleção é letal para a levedura. Estes 
genes são estruturalmente e funcionalmente homólogos dos proto-oncogenes RAS dos 
mamíferos. Esta conservação permite a utilização da levedura para o estudo do KRAS. 
Deste modo, o primeiro objectivo deste trabalho foi construir um conjunto de estirpes de S. 
cerevisiae (BY4741 haplóide wild type, ras1Δ e ras2Δ como receptoras) a expressar o 
KRASwt humano, usando um plasmídeo de expressão. O segundo objectivo foi a 
realização de um screening fenotípico das leveduras humanizadas, bem como das estirpes 
não transformadas. O efeito da expressão do KRASwt foi avaliado na resposta ao stress 
celular, crescimento, envelhecimento cronológico, progressão do ciclo celular e no 
crescimento invasivo haplóide.  
De acordo com os resultados, a expressão heteróloga do KRASwt na levedura (1) 
teve um efeito negativo, ou nulo, na resistência aos diferentes stresses (temperatura, pH, 
osmótico e oxidativo); (2) reduziu o crescimento em fontes de carbono não fermentáveis; 
(3) aumentou a capacidade de adesão; (4) estimulou o crescimento invasivo haplóide na 
estirpe ras2Δ; (5) modificou o padrão de divisão das células wild-type; (6) alterou a 
proliferação celular; e (7) diminuiu a longevidade cronológica. Os resultados indicaram que 
a expressão do KRASwt na estirpe wild type, levou a uma possível hiperativação da via de 
sinalização RAS/cAMP/PKA, responsável pela diminuição da resistência ao stress e da 
longevidade. Este estudo também demonstrou a relevância do background da levedura 
para a possível obtenção de diferentes resultados, independentemente das condições 
usadas. O presente trabalho contribuiu para o conhecimento do mecanismo de ação do 
KRAS através da utilização da levedura como organismo modelo. Além disso, todos os 
resultados obtidos farão parte de uma plataforma de fenótipos de levedura para futuros 
testes farmacológicos. 
  
viii 
 
 
 
ix 
 
Table of Content 
Agradecimentos ........................................................................................................................................... iii 
Abstract ......................................................................................................................................................... v 
Resumo ...................................................................................................................................................... vii 
Table of Content .......................................................................................................................................... ix 
List of Tables and Figures ............................................................................................................................ xi 
1. Introduction ........................................................................................................................................ 3 
1.1 Saccharomyces cerevisiae as a model system in biological research ........................................ 3 
1.1.1 The yeast life cycle ............................................................................................................. 4 
1.1.2 The signalling pathways ..................................................................................................... 7 
1.1.2.1 Mitogen activated protein kinases (MAPK) pathways .......................................... 7 
1.1.1.1 Nutrient signalling pathways .................................................................................. 9 
1.1.1.2 Signalling crosstalk in particular cell responses ................................................ 10 
1.1.1.2.1 MAPK cascade and RAS/cAMP/PKA pathway in filamentous growth response .. 10 
1.1.1.2.2 CWI/PKC, TOR and RAS/cAMP/PKA pathways in oxidative stress response ..... 11 
1.2 Mammalian RAS pathway ......................................................................................................... 13 
1.3 RAS/cAMP/PKA pathway in Saccharomyces cerevisiae ........................................................... 16 
1.3.1 RAS genes........................................................................................................................ 16 
1.3.2 RAS/cAMP/PKA signalling pathway ................................................................................. 17 
1.3.2.1 RAS/cAMP/PKA pathway in response to different stresses .............................. 19 
1.3.2.2 RAS/cAMP/PKA pathway in filamentous growth ................................................ 19 
1.3.2.3 RAS/cAMP/PKA pathway in cellular aging .......................................................... 20 
1.3.2.4 The expression of human Ras isoforms in S. cerevisiae ................................... 21 
1.4 Rationale and aims of the present work .................................................................................... 21 
2. Material and Methods....................................................................................................................... 25 
2.1 Strains and growth conditions ................................................................................................... 25 
2.2 Plasmids .................................................................................................................................... 26 
2.3 Preparation of E. coli competent cells ....................................................................................... 27 
2.4 Polymerase chain reaction (PCR) ............................................................................................. 27 
2.5 DNA electrophoresis in agarose gel .......................................................................................... 27 
2.6 DNA enzymatic digestion and ligation ....................................................................................... 28 
2.7 Transformation of E.coli and plasmid extraction ........................................................................ 29 
2.8 Transformation of S. cerevisiae and verification by PCR ........................................................... 29 
x 
 
2.9 Western Blot analysis ................................................................................................................ 30 
2.9.1 Yeast protein extraction and precipitation ......................................................................... 30 
2.9.2 SDS-PAGE (Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis) .............. 31 
2.9.3 Western Blot assay ........................................................................................................... 31 
2.10 Phenotype Screening ................................................................................................................ 31 
2.10.1 Growth parameters in yeast batch cultures ...................................................................... 31 
2.10.2 Growth assays in solid medium ........................................................................................ 32 
2.10.3 Adherence to agar and Invasion ....................................................................................... 33 
2.10.4 Filamentous growth .......................................................................................................... 33 
2.10.5 Chronological aging assay ................................................................................................ 34 
2.10.6 Cell cycle analysis ............................................................................................................ 34 
3. Results and Discussion ................................................................................................................... 37 
3.1 Heterologous expression of human KRASwt cDNA in Saccharomyces cerevisiae ..................... 37 
3.1.1 KRASwt plasmid harbouring construction .......................................................................... 37 
3.1.2 Transformation of S. cerevisiae BY4741 with p426/KRASwt ............................................. 40 
3.1.3 Confirmation of KRASwt expression in the BY4741 positive transformants ....................... 41 
3.2 Phenotypic effects of the KRASwt expression in S. cerevisiae and functional complementation of 
the RAS genes deletion. ......................................................................................................................... 41 
3.2.1 Stress phenotypes associated with KRASwt expression.................................................... 42 
3.2.1.1 High-temperature stress ........................................................................................ 42 
3.2.1.2 High osmotic stress ............................................................................................... 44 
3.2.1.3 Oxidative stress ..................................................................................................... 45 
3.2.1.4 High and low pH ..................................................................................................... 47 
3.2.2 Effect of KRASwt expression on growth on non-fermentable carbon sources ................... 47 
3.2.3 Effect of KRASwt expression in the haploid invasive growth .............................................. 48 
3.2.4 Effect of KRASwt expression on chronological life span and cell cycle .............................. 53 
3.2.4.1 Chronological life span ......................................................................................... 53 
3.2.4.2 Cell cycle analysis ................................................................................................. 55 
3.2.5 Comments on KRASwt-associated phenotyping................................................................ 57 
4. Final Remarks ................................................................................................................................... 61 
5. References ........................................................................................................................................ 67 
 
  
xi 
 
List of Tables and Figures 
Figure 1. Scheme of yeast life cycle showing haploid and diploid states. Withdrawn from Herskowitz I 
(1988) [20]. …………………………………………………………………………………………………………… 5 
Figure 2. Morphological forms possible in S. cerevisiae as compared with the human commensalist and 
opportunistic pathogen Candida albicans. Adapted from Gancedo J (2001) [24], Cullen et al. (2000) [25], 
William et al. (2012) [29], Wightman et al. (2004) [30] and www.uni-goettingen.de/en/425121.html. .......... 6 
Figure 3. Phases of S. cerevisiae mitotic cell cycle. Adapted from Hartwell L.H (1974) [32]. ……………… 7 
Figure 4. Brief outline of the yeast MAPK pathways. Withdrawn from Hohmann S (2002) [40]. …………... 8 
Figure 5. RAS/cAMP/PKA signalling pathway in S. cerevisiae. Adapted from Tamanoi F (2011) [42]. …... 9 
Figure 6: Schematic representation of the integrative yeast cellular response to glucose depletion and 
oxidative stress. Withdrawn from Weinberger et al. (2010) [57]. ……………………………………………... 12 
Figure 7: Schematic representation of the influence of TOR over WCI/PKC pathway via Rom2/Rho1 that 
also react to the effect of cell surface sensors of cell wall integrity, namely Mtl1. A) Adapted from Torres et 
al. (2002) [60] B) adapted from Heinisch (2014) https://www.biologie.uni-
osnabrueck.de/forschung/sfb_944/sfb_944_home/projects.html. .............................................................. 12 
Figure 8: Schematic representation of the balance between different pathways that contributes to opposite 
effects depending on external stimuli, namely TOR, RAS/ cAMP/PKA. Withdrawn from Ruckenstuhl et al. 
(2010) [61]. …………………………………………………………………………………………………………. 13 
Figure 9. A general view of RAS signalling pathway in human cells. Adapted from Hezel (2006) [63]. … 15 
Figure 10. Schematic representation of p416GPD and p426GPD expression plasmids. ………………… 26 
Figure 11. Electrophoretic analysis of PCR amplified fragment originating from pLenti/KRASwt (lane 1). 
Molecular weight marker: Ȝ DNA/Eco47I (Fermentas). Red box: putative amplified KRASwt. …………….. 38 
Figure 12. Electrophoretic analysis of the p426/KRASwt plasmid DNA extracted from E.coli XL1-Blue 
clones and double digested with HindIII and XhoI – Lanes 1 and 2. Molecular weight marker: Ȝ DNA/Eco-
471 (Fermentas). Red box: Digested KRASwt fragment. ……………………………………………………… 39 
Figure 13. Electrophoretic analysis of PCR amplified KRASwt originating from S. cerevisiae BY4741 
transformed with the p426GPD/KRASwt: wt (lane 2 to 4), ras1∆ (lane 5) and ras2∆ (lane 6 to 7). The KRAS 
insert corresponds to a band with a molecular weight of approximately 560 pb. As a positive control the 
pLenti/KRASwt was identically amplified by PCR (lane 1). Molecular weight marker: Ȝ DNA/Eco47I 
(Fermenta). Red box: Bands corresponding to KRASwt fragment. …………………………………………… 40 
Figure 14. Western Blot analysis of KRASwt expression in S. cerevisiae BY4741. Total protein extracts of 
wt (A), ras1Δ (B) and ras2Δ (C), transformed with the empty p426GPD (Ø) and p426GPD/KRASwt, were 
probed against anti-KRas antibody (Sigma). Each column shows the result of blotting positive (+) or 
negative (-) transformants. ………………………………………………………………………………………... 41 
Figure 15. Phenotypic evaluation of the sensitivity to high temperature of BY4741 S. cerevisiae set of 
strains expressing human KRASwt. Strains were pre-grown on YNB w/ glucose and used for drop-out 
assay (ten-fold serial dilutions, 5 µl/ drop) on YNB w/ 2% glucose and incubated for 2 days at 37 °C. These 
results are representative of independent triplicates. ………………………………………………………….. 43 
Figure 16. Phenotypic evaluation of the sensitivity to osmotic stress of BY4741 S. cerevisiae set of strains 
expressing human KRASwt. Strains were pre-grown on YNB w/glucose and used for drop-out assay (ten-
fold serial dilutions, 5 µl/ drop) on YNB w/ 2% glucose with NaCl or sorbitol and incubated for 2 days at 30 
°C. These results are representative of independent triplicates. ……………………………………………... 45 
xii 
 
Figure 17. Phenotypic evaluation of the sensitivity to osmotic stress of BY4741 S. cerevisiae set of strains 
expressing human KRASwt. Strains were pre-grown on YNB w/ glucose and used for drop-out assay (ten-
fold serial dilutions, 5 µl/ drop) on YNB w/ 2% glucose and H2O2 and incubated for 3 days at 30 °C. These 
results are representative of independent triplicates. ………………………………………………………….. 46 
Figure 18. Phenotypic evaluation of the sensitivity to osmotic stress of BY4741 S. cerevisiae set of strains 
expressing human KRASwt. Strains were pre-grown on YNB w/ glucose and used for drop-out assay (ten-
fold serial dilutions, 5 µl/ drop) on YNB w/ 2% ethanol or glycerol, or 2% glucose for control. Results show 
cultures incubated at 30 °C for 2 days in the case of glucose, and 10 days for the other carbon sources. 
These results are representative of independent triplicates. ………………………………………………….. 48 
Figure 19. Assaying adherence to the agar of BY4741 S. cerevisiae set of strains expressing human 
KRASwt. Strains were pre-grown on YNB w/ glucose and equal concentrations of cells were spotted onto 
plates of YNB w/o glucose, and incubated for 7 days at 30 °C. The adherence was verified after washing 
the surface of the agar with a gentle stream of running water. These results are representative of 
triplicates. …………………………………………………………………………………………………………… 49 
Figure 20. Assaying agar invasion of BY4741 S. cerevisiae set of strains expressing human KRASwt: wt 
(A); ras1∆ (B); ras2∆ (C); wt p426ø (D); ras1∆ p426ø (E); ras2∆ p426ø (F); wt KRASwt (G); ras1∆ KRASwt 
(H) and ras2∆ KRASwt (I). Assays were performed as in Fig.19 except that plates were incubated for 3 
weeks. Agar was sliced with a scalpel, and sections were set perpendicular to the plan of invasion for 
visualization. ………………………………………………………………………………………………………... 50 
Figure 21. Morphological appearance of cells of the BY4741 S. cerevisiae set of strains expressing human 
KRASwt: wt (A); ras1∆ (B); ras2∆ (C); wt p426ø (D); ras1∆ p426ø (E); ras2∆ p426ø (F); wt KRASwt (G); 
ras1∆ KRASwt (H) and ras2∆ KRASwt (I). Cells were starved in YNB w/o glucose for 5 days at 30ºC and 
examined by light microscopy. White arrows in panel G indicate bipolar budding. ………………………… 52 
Figure 22. Survival of the BY4741 S. cerevisiae set of strains expressing human KRASwt during 
chronological aging phase. Cells were inoculated in YNB w/ 2% glucose and survival was monitored by 
c.f.u. Assays took place after exponential phase ended: T0 corresponds to 100% survival. Results 
correspond to one (preliminary) experience. …………………………………………………………………… 54 
Figure 23. Cell cycle analysis by flow cytometry of the BY4741 S. cerevisiae set of strains expressing 
human KRASwt. Strains were grown on YNB w/ 2% glucose up to mild-exponential phase. Results 
correspond to one (preliminary) experience. …………………………………………………………………… 55 
Figure 24. Cell cycle analysis by flow cytometry of the BY4741 S. cerevisiae set of strains expressing 
human KRASwt. Strains were grown on YNB w/ 2% glucose up to late-stationary phase. Results 
correspond to one single (preliminary) experience. ……………………………………………………………. 56 
 
Table 1. The S. cerevisiae BY4741 and E.coli strains used in present work. ............................................. 25 
Table 2. Primers used for amplification of human KRASwt fragment. ......................................................... 28 
Table 3. Growth conditions tested using YNB as base medium. ................................................................ 32 
Table 4: Compared genetic backgrounds of BY4741 and the different strains used in the literature to 
describe Ras-related phenotypes. ……………………………………………………………………………….. 51 
Table 5. Specific growth rates (µg) of S. cerevisiae BY4741 wt, ras1∆ and ras2∆ untransformed, 
harbouring p426ø, and expressing KRASwt strains, grown in YNB medium with 2% glucose. Each value is 
the mean of three independent experiments. …………………………………………………………………... 53 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter I  
 
Introduction 
  
  
 
Chapter I – Introduction 
 
3 
 
1. Introduction 
1.1 Saccharomyces cerevisiae as a model system in biological 
research 
The Saccharomyces cerevisiae genome was the first eukaryotic genome to be fully 
sequenced in April 1996 [1], and over the years the data thus generated fuelled whole 
genome scale screening methods, including microarrays, two-hybrid analysis and the 
application of deletion and overexpression libraries [2]. The whole yeast nuclear 
genome contains a haploid set of 16 well-characterized chromosomes, ranging in size 
from 200 to 2,200 kb. In contrast to the genomes of multicellular organisms, the yeast 
genome is highly compact, with genes representing 72% of the total sequence (<2% in 
the human genome). S. cerevisiae has therefore a genome with a small size and low 
degree of complexity as compared with higher Eukaryotes. Furthermore, as all other 
eukaryotic organisms, the yeast S. cerevisiae also contains an additional extranuclear 
mitochondrial genome [3].  
A considerable amount of knowledge about basic cellular processes originated 
from model organisms that include the simpler eukaryote S. cerevisiae [4]. The 
increasing amount and complexity of work performed in this organism, which occurred 
during the last decades, solidified yeast position at the forefront of eukaryotic cellular 
and molecular biology, facilitating the establishment of new fields of study like systems 
biology. This goes beyond the functions of individual genes and proteins, focusing on 
how these interact and work together to determine major properties underlying life and 
major biological properties and behaviours [5]. The reasons underlying include the 
many technical advantages that yeasts present over other systems for using in 
research and biotechnology, namely the short generation time and the high amenability 
to genetic modifications, as well as the ability to control its growth and division by 
adjusting environmental conditions [6]. Importantly, it accrues the fact of yeast being a 
GRAS organism, inexpensive to maintain and propagate, and easy to cultivate and 
store [3, 7, 8].  
Yeast has been recognised the status of model organism for research of complex 
processes, as a simple eukaryotic organism whose genome can be easily manipulated 
allowing suitable analysis and efficient assessment of gene products from other 
Eukaryotes, including man [6, 9]. Although important aspects of human diseases lie 
beyond the reach of S. cerevisiae due to organisms’ multicellular nature and 
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complexity, yeast is still used for unveiling molecular processes involved in some 
diseases based on their high degree of conservation [2, 7]. These are mostly basic 
cellular processes such as cell cycle control, DNA replication, recombination, repair, 
protein folding, trafficking, programmed cell death, and metabolic and regulatory 
mechanisms [10-12].  
Moreover, many human genes that are mutated or that have their expression 
changed in tumour cells have yeast orthologues (approximately 30% of genes 
according to Françoise Foury) [13]. The fact that a gene codifying for a protein implied 
in a disease is conserved in yeast, opens the possibility to directly study its function by 
expressing it in yeast, or by integrating it into the yeast genome [5], namely to 
complement the correspondent yeast gene deletion [9, 14]. Yeast was used to analyse 
molecular mechanisms of several human diseases, sometimes of rather unexpected 
nature like neurological diseases [15-18], or cancer related signalling pathways [7, 8]. 
As said above, this was achieved by directly studying an endogenous protein 
orthologue of a human involved in the disease [15-18] or through the heterologous 
expression of human disease associated proteins [16, 19]. The use of yeast, 
expressing human genes or not, is therefore also of great value for high-throughput 
phenotyping and pharmacological assaying [6]. 
 
1.1.1 The yeast life cycle 
The yeast life cycle (Fig. 1) comprehends two possible reproductive cycles, a 
mitotic asexual cycle in which cells reproduce by budding, and a sexual-like meiotic 
cycle in which cells sporulate, germinate, mate and then reproduce by budding. Mating 
cells can be genetically different from each other - heterothallic yeast – or identical – 
homothallic yeast. S. cerevisiae is heterothallic and produces two haploid mating types, 
MATa and MATα. After conjugation, diploid cells can reproduce asexually in identical 
fashion to haploid cells (by budding), or can suffer sporulation entering meiosis and 
consequently producing four haploid spores, which in turn can also germinate and 
reproduce asexually (by budding), or can mate returning the culture to diploid state 
[20]. 
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Figure 1. Scheme of yeast life cycle showing haploid and diploid states. Withdrawn from Herskowitz I 
(1988) [20]. 
 
Inversely to humans, S. cerevisiae lives mostly as a unicellular organism, yet as all 
other microbes, it can form multicellular aggregates, such as colonies or biofilms that 
are complex, organized, multicellular structures [20, 21]. Additionally, in certain stress 
conditions such as carbon or nitrogen starvation or oxygen limitation, S. cerevisiae 
cells can suffer a morphological switch characterized by changes in cell polarity and 
shape with consequences in cell adhesion and invasive behaviour [22, 23]. Cells 
become elongated, exhibit a polar budding and remain attached after cytokinesis, 
switching from growth as independent yeast-form cells on the surface of medium to 
branching chains of cells, that spread over and into the agar to forage for nutrients, 
known as filamentous growth [22-24]. In diploid strains this dimorphic switch is 
characterized by pseudohyphae formation (Fig. 2), while the haploid strains have an 
more subtle switching displaying only limited changes in cell morphology but an 
increased cell-cell adhesion, known as haploid invasive growth phenotype (Fig. 2) [23]. 
In addition, the pseudohyphal growth is a behaviour characteristic of diploids starved 
for nitrogen, whereas the similar haploid invasive growth is induced by fermentable 
carbon limitation [25]. Accordingly, stress-induced signalling has an important role in 
filamentous growth [23, 26].  
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Like all eukaryotic cells, yeasts reproduce while they are young, age and die when 
they are old. There are two ways of describing aging in yeasts. Replicative aging 
quantifies aging by the number of daughter cells produced by each mother cell before 
senescence, and chronological aging, quantifies aging by the length of time that a 
yeast cell can survive in a non-dividing state [27]. Finally, death can happen via 
necrose or apoptose, which can also happen upon different stimuli regardless to the 
yeast age [28]. 
 
 
Figure 2. Morphological forms possible in S. cerevisiae as compared with the human commensalist 
and opportunistic pathogen Candida albicans. Adapted from Gancedo J (2001) [24], Cullen et al. (2000) 
[25], William et al. (2012) [29], Wightman et al. (2004) [30] and www.uni-goettingen.de/en/425121.html. 
 
S. cerevisiae asexual cycle, called mitotic cell cycle initiates with an unbudded cell 
(mother cell) in the G1 checkpoint (Fig. 3). The end of G1 checkpoint is marked by the 
occurrence of the spindle plaque duplication and the beginning of DNA synthesis and 
bud emergence (daughter cell). At this stage, the unbudded cell starts polarized 
growth, predominantly at its apex, ensuring correct assembly of a new bud and septum 
formation before cell division [31]. Cells then enter S phase - DNA synthesis - and 
plaque separation occurs. The plaques separate until the complete spindle is formed 
and the bud size continues to grow along the remaining cycle. The finish of G2 
checkpoint is marked by the nucleus migration to the cell neck where the spindle 
elongation occurs and the nuclear division begins, which in turn finishes during M 
phase followed by cytokinesis. The final event is the cell wall separation with the 
consequent formation of two unbudded cells, which does not occurs during filamentous 
growth [32]. This polarized cell division is characterized by two genetically programmed 
different spatial patterns, axial for haploid cells, and bipolar for diploid cells [33]. 
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The major cell cycle control point is in the regulatory G1 time lapse called START. 
At start, yeast cell integrates many intra and extracellular signals, being then committed 
to continue proliferation, being switched to differentiation pathways, or entre stationary 
phase [34]. At START point the yeast cell needs to achieve a critical size in order to 
bud and progress into S phase, being the G1 phase delayed until this critical mass is 
reached [35]. The critical cell mass required for budding relates to the nutritional 
conditions of the cells, which also modulate the degree of asymmetry of cell division. 
For example, in poor medium usually the parent cells are large and the daughters are 
very small, whereas in rich medium the asymmetry between parent and daughter cells 
is reduced [35, 36]. The switch between yeast and pseudohyphae forms also involves 
important changes in the pattern of progression through the cell cycle. In pseudohyphal 
growth, there is an extended G2/M period and the daughter cell reaches the same size 
of the mother cell. So that both cells can start a new cycle synchronously, while in the 
yeast form, G1 phase presents itself as the extended cell cycle period, and the bud 
separates from the mother before reaching considerable size, starting both cells a new 
cell cycle independently [24]. 
 
 
Figure 3. Phases of S. cerevisiae mitotic cell cycle. Adapted from Hartwell L.H (1974) [32]. 
 
1.1.2 The signalling pathways 
1.1.2.1 Mitogen activated protein kinases (MAPK) pathways 
MAPK pathways are highly conserved signalling operating units, required in all the 
eukaryotic cells to properly activate specific or general responses, which allow cells to 
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cope with different external stimuli, like all types of stress, nutrients availability, growth 
factors and cytokines, ensuring cell survival [37]. In S. cerevisiae MAPKs cascades 
participates in transmitting several extracellular signals controlling mating, 
morphogenesis, proliferation and cellular integrity in response to nutrients limitation, or 
osmotic, oxidative, temperature and pH stresses [38]. S. cerevisiae has several MAP 
kinases, allocated to six distinct MAPK pathways [39, 40] (Fig. 4):  
 Fus3 – from the mating pheromone response pathway, 
 Kss1 – common to the filamentous development and the cell wall integrity 
pathways, 
 Hog1 – from the high osmolarity glycerol (HOG) pathway, 
 Slt2/Mpk1 – cell wall integrity (CWI)/ protein kinase C (PKC) pathway, and  
 Smk1 – from the spore wall assembly pathway. 
 
Figure 4. Brief outline of the yeast MAPK pathways. Withdrawn from Hohmann S (2002) [40]. 
 
These are upstream controlled by MAPKKs and MAPKKKs that may ensure some 
degree of crosstalk and a common answer to different stimuli. An example is the 
stimulation of the synthesis and subsequent function of the general stress response 
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transcription factors Msn2 and Msn4 which fine tuning allows the cell to respond to a 
series of different environmental constraints, including osmotic, heat and oxidative 
stresses [41]. 
 
1.1.1.1 Nutrient signalling pathways 
In yeast, a major signalling pathway activated by glucose is the cAMP/PKA (cyclic 
adenosine monophosphate/ protein kinase A) pathway, which regulates many aspects 
of cellular physiology, according to nutrients availability [36]. cAMP is synthetized from 
ATP from adenylate cyclase, which activity is controlled by two distinct G-protein 
systems, the Ras1/Ras2 and the Gpr1/Gpa2 proteins. Ras1/Ras2-dependent 
adenylate cyclase activity is further controlled by the exchange factors Cdc25 as well 
as the GTPase-activating proteins Ira1 and Ira2 (Fig. 5). 
 
Figure 5. RAS/cAMP/PKA signalling pathway in S. cerevisiae. Adapted from Tamanoi F (2011) [42].  
 
 
The activation of cAMP/PKA pathway can be triggered by transferring yeasts from a 
poor to a rich carbon source environment [43], which favours rapid growth and cell 
proliferation by stimulating the glycolytic flux, and repressing the stress response and 
the expression of genes required for respiratory metabolism [36, 44]. Alternatively, 
intracellular acidification can have an identical effect [43]. Gpr1/Gpa2 G-protein-
coupled receptor system is required for glucose activation of cAMP synthesis, while 
Ras1/Ras2, in particular Ras2, may stimulate cAMP synthesis in response to either 
glucose or intracellular acidification [36, 43].  
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In addition to cAMP/ PKA pathway, the yeast also has other two nutrient signalling 
pathways, TOR (target of rapamicyn) and the less well-known Sch9, partially 
conserved in higher Eukaryotes [39, 45]. When glucose or other nutrients are present, 
the three pathways are active conveying signals that promote cell growth and division. 
In contrast, if the nutrients are scarce, the reduction of the Sch9, TOR, and cAMP/PKA 
signalling activity, causes cell division arrest and the activation of mechanisms 
responsible for cellular protection [46]. TOR and Sch9 act cooperatively with PKA to 
regulate multiple downstream processes, including autophagy, protein synthesis, 
mitochondrial function and stress resistance, in response to nutrient availability but also 
to other environmental signals [47]. Studies of chronological aging in S. cerevisiae led 
to the discovery that Sch9, TOR, and cAMP/PKA pathways are pro-aging pathways, 
negatively influencing the life span [48]. In particular, the nutrient-responsive Sch9 
kinase, adenylate cyclase (Cyr1) and Tor1 are negative regulators of chronological life 
span (CLS). Accordingly, the deletion of SCH9 and TOR1 increased CLS [49]. This 
extension involves multiple stress-responsive transcription factors, namely the above 
mentioned Msn2 and Msn4, which once up-regulated lead to an increase of the levels 
of superoxide dismutase and catalase, thereby minimizing oxidative stress and cellular 
damage [50]. This demonstrates the association between longevity extension and 
ability to respond to stress, which has been observed in several organisms [27, 51]. 
 
1.1.1.2 Signalling crosstalk in particular cell responses 
1.1.1.2.1 MAPK cascade and RAS/cAMP/PKA pathway in filamentous 
growth response 
Evolutionarily conserved signalling pathways encompassing crosstalk and 
feedback mechanisms regulate the filamentous growth in S. cerevisiae. In particular, 
the morphogenetic switch requires the cooperation of two different signalling pathways, 
the filamentous MAPK cascade and the RAS/cAMP/PKA pathway [24]. PKA stimulates 
the expression of the MAPK cascade–controlled genes - TEC1 [52] and FLO11 [53] 
possessing a Filamentation Response Element (FRE) in their promoters. FLO11 
encodes a cell-surface flocculin required for filamentous growth in haploid and diploid 
strains [53]. As above referred, filamentous growth involves changes in the budding 
and elongation patterns, and invasive ability. Although these cellular processes are 
interconnect, they are not always controlled by the same elements. For instance, 
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Ste12p of MAPK cascade is required for cell elongation, while Tpk2p of cAMP/PKA 
pathway controls the pattern of budding, namely the budding switch, and both are 
involved in the invasive process [24].  
 
1.1.1.2.2 CWI/PKC, TOR and RAS/cAMP/PKA pathways in oxidative stress 
response 
Oxidative stress has been implicated in a large variety of biological processes 
including aging and apoptosis. Reactive oxygen species (ROS), including hydrogen 
peroxide (H2O2), are generated endogenously in many cells as a consequence of 
metabolic processes, mostly at mitochondrial level [54]. By contributing to 
mitochondrial damage, ROS are also important in redox signalling from the organelle to 
the rest of the cell. As a result, aerobic organisms sense redox perturbations and 
develop several different adaptive mechanisms in order to acquire survival capacity 
[55]. S. cerevisiae was used to study the signal transduction pathways involved in the 
response to oxidative stress. In this yeast, TOR, CWI/PKC and RAS/cAMP/PKA, are 
the best characterized routes crosstalking in transducing the oxidative signal [38, 56]. 
They further react to glucose starvation in a similar manner [57] (Fig. 6). Mtl1 is a cell 
surface protein required for survival under oxidative stress [58]. Mtl1 transmits the 
oxidative signal to the CWI/PKC pathway’s Rom2, which then activates the Rho1, this 
way inducing the activation of Slt2 [59]. Furthermore, in conditions of nutrient depletion 
and oxidative stress Mtl1 negatively influences CWI/PKC through the inhibition of 
Rom2, which is also inhibited indirectly via Tor1 and Ras2 inhibition through the 
inhibition by the same stimuli (Fig. 7). This repression eventually has several outputs, 
such as the decrease of cAMP, the activation of a wide subset of genes potentially 
regulated by the general stress response dual transcription factor Msn2/Msn4, and the 
ribosomal gene repression [38, 56]. This extensive crosstalk between culminates in the 
further interaction with the RAS/cAMP/PKA pathway in processes that ultimately lead 
to aging (Fig. 8). 
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Figure 6: Schematic representation of the integrative yeast cellular response to glucose depletion and 
oxidative stress. Withdrawn from Weinberger et al. (2010) [57]. 
 
 
 
 
Figure 7: Schematic representation of the influence of TOR over WCI/PKC pathway via Rom2/Rho1 
that also react to the effect of cell surface sensors of cell wall integrity, namely Mtl1. A) Adapted from 
Torres et al. (2002) [60]; B) adapted from Heinisch (2014) https://www.biologie.uni-
osnabrueck.de/forschung/sfb_944/sfb_944_home/projects.html. 
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Figure 8: Schematic representation of the balance between different pathways that contributes to 
opposite effects depending on external stimuli, namely TOR, RAS/ cAMP/PKA. Withdrawn from 
Ruckenstuhl et al. (2010) [61]. 
 
 
1.2 Mammalian RAS pathway 
Ras proteins are the founders of a large superfamily of GTPases, very conserved 
throughout all eukaryotic species, including 150 human members distributed into 5 
distinct families, RAS, RHO, RAB, ARF and RAN [62, 63]. Each family is responsible 
for the control of certain cellular processes. For example, the RAS family controls cell 
growth, having thus a potential role in the cancer development [64]. Ras proteins are 
guanine nucleotide-binding proteins that function as GDP/GTP molecular switches. 
They are activate in response to the activation of a growth factor receptor by the 
Guanine Nucleotide Exchange Factors (GEFs). These stimulate the intrinsic GDP/GTP 
exchange activity of Ras proteins promoting the formation of the active RAS-GTP form. 
Otherwise, GTPase-Activating Proteins (GAPs) stimulate the intrinsic GTP hydrolysis 
activity of Ras proteins promoting the formation of the inactive RAS–GDP form. 
Consecutively, the active Ras protein will work as an adaptor protein recruiting 
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effectors from cytosol to the plasma membrane, where they are activated through the 
interaction with proteins and lipids, producing intracellular signals to modulate cellular 
behaviour [62, 65, 66].  
In mammalian cells, there are at least three functional RAS genes, KRAS, HRAS 
and NRAS, encoding 21 kD proteins with 189 (KRas4B) and 188 (KRas4A, HRas and 
NRas) amino acids. KRas4A and 4B are alternative splice variants of KRAS at the level 
of C-terminal, which is important for post-translational modification [67]. These human 
RAS isoforms are particularly homologous between each other, sharing nearly 85% 
sequence homology in the first 165 amino acids (the N-terminal) and having a 
significant variation in 25 remaining amino acids (the C-terminal), except for the C-
terminal CAAX box hypervariable region [67, 68]. This region is useful to distinguish 
between different Ras proteins [69] and does not implicate significant structural 
differences, since RAS family members, although functionally different, are closely 
related at structurally level [70].  
Ras proteins regulate cell fates by coupling receptor activation to downstream 
effector pathways that control several cellular responses including proliferation, 
differentiation, survival and apoptosis [71]. To regulate signal transmission from cell 
surface receptors to intracellular signalling cascades, Ras proteins were firstly 
considered to necessarily localize in the plasma membrane [64, 66]. Nevertheless, Ras 
proteins localized in different cellular membranes could also signal, recruiting distinct 
upstream and downstream partner proteins and activating different signalling pathways 
[62, 65, 70]. Exception is the role of Ras proteins in oncogenesis-related processes, 
which apparently require their association with the inner face of plasma membrane 
[72].  
The above-mentioned “hypervariable” region of RAS promotes the traffic of Ras 
proteins to the plasma membrane and their specific localization. Thus, the interactions 
of Ras proteins with the plasma membrane can differ from one RAS isoform to the 
other due to their different structure of the hypervariable domain [69]. All Ras proteins 
undergo a series of posttranslational modifications at their C-terminus namely in their 
CAAX motif. These modifications, which comprise farnesylation, cleavage, methyl 
esterification and palmitoylation, are essential for protein localization and biological 
activity. In particular, palmitoylation is essential for the tight association of Ras proteins 
with the plasma membrane, since after the first three modification steps (farnesylation, 
proteolysis, and methylation), Ras proteins remains largely cytosolic. For Kras, which is 
not palmitoylated, a stretch of basic residues (lysine) located just upstream of t
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CAAX motif is required for plasma membrane localization [73]. RAS-membrane 
interactions can also depend on the activation state of specific RAS isoforms [72].  
In mammalian cells, activated Ras proteins stimulate various pathways, being the 
Raf-mitogen-activated kinase (MAPK) and PI3K the best characterize Ras-controlled 
effectors (Fig. 9) [71]. The RAS/Raf/MEK/ERK signalling pathway has been shown to 
play key role in the transmission of proliferative signals originating from membrane-
bound receptors [74]. Raf stimulates cell proliferation and differentiation by the MAPK 
pathway, while PI3K pathway is involved in the regulation of cell survival, cell cycle 
progression, cell size and cellular proliferation through numerous downstream effectors 
including Akt [65, 75, 76]. Furthermore, the survival signals induced by some receptors 
are mostly mediated by PI3K/Akt and it is known that mutations in this pathway are 
frequent in many cancers, namely, activating mutations of the PI3K catalytic subunit, 
and loss-of-function mutations of the PTEN tumour suppressor [75, 76].  
 
  
Figure 9. A general view of RAS signalling pathway in human cells. Adapted from Hezel A.F (2006) [63].
 
 
The HRas, KRas and NRas proteins are widely expressed, being KRas 
expressed in almost all types of eukaryotic cells [64]. KRAS is essential for normal 
cellular development while neither N- nor HRAS are, therefore having a well recognize 
role in tumorigenesis [77, 78]. The most prevalent oncogenic RAS-associated 
mutations in KRAS are point mutations causing amino acids substitution in codons 12, 
13 and 61 [65, 67, 79]. These mutations hamper the capacity of GEFs to interact with 
KRas protein, producing constitutively activated KRas, and consequently, an improper 
activation of the pathway, ultimately generating a malignant phenotype [65, 71]. 
Concurrently, the duration and the intensity of RAS signalling regulate the 
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developmental programs in specific cellular types [71]. Furthermore, KRAS locus in 
humans encodes two splice variants, for which mutations in KRAS have the potential to 
interfere in splicing events [69].  
 
1.3 RAS/cAMP/PKA pathway in Saccharomyces cerevisiae 
1.3.1 RAS genes  
S. cerevisiae has two isoforms of RAS genes, expressing extremely homologous 
small GTPases moderately redundant at phenotype level [26, 80]. Moreover, RAS1 
and RAS2 are structurally and functionally homologs of the mammalian RAS proto-
oncogenes [81]. RAS1 and RAS2 genes constitute an essential yeast gene family, 
since the deletion of both is lethal to the yeast cells [82]. RAS1 is located on 
chromosome XV, 7 cM from ADE2 and 63 cM from HIS3, and encodes a protein of 309 
amino acid residues. On the other hand, RAS2 is located on chromosome XIV, 2 cM 
from MET4, encoding proteins of 322 amino acid residues [42, 83]. Ras1 and Ras2 are 
nearly 90% homologous in the region corresponding to the N-terminal first 180 amino 
acids, but diverge in the remaining amino acid sequence. The N-terminal domain is 
also the region of greatest similarity with the mammalian Ras proteins, with nearly 90% 
homology between positions 10 - 90 and 3 - 83 of, respectively, the yeast and the 
mammalian Ras proteins. On the other hand, another major difference between these 
proteins lies in the sequence and size of their C-terminal, particularly in the 
hypervariable region including CAAX box, which in the case of Ras1 and Ras2 is much 
more extended [73, 84]. 
As mammalian Ras proteins, also yeast Ras proteins undergo a series of post-
translational modifications of their C-termini, including farnesylation and palmitoylation 
that are required for targeting the proteins to the cytoplasmic face of the plasma 
membrane and for biological activity of the protein. Ras proteins biological activity 
requires farnesylation, while palmitoylation is required for their localization to the 
plasma membrane. The essential role of the farnesyl moiety on yeast Ras1/2 proteins 
is to enable the efficient activation of adenylyl cyclase and response to membrane-
associated GEFs, i.e., nucleotide exchange activity mediated by membrane bound full-
length Cdc25 and Sdc25 exchange factors [73, 84]. In the N-terminal domain positions 
12, 13, 59, 61, or 63, amino acid substitutions can activate the transforming potential of 
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the mammalian Ras proteins. At the equivalent positions, the yeast RAS genes encode 
the same amino acids. This homology could reflect both a highly conserved 
biochemical function and a mechanism for regulating that function [83, 85]. 
As mentioned above, Ras1 and Ras2 proteins are biologically equivalent, although 
transcriptional and translational controls determine under what physiological conditions 
either Ras protein will be expressed [86]. As a consequence of a fluid transcriptional 
and translational regulation, no clear-cut phenotype was ever apparent for ras1∆ 
mutant strains [86]. The following examples allow a deeper understanding of the 
resulting phenotyping conundrum: 
a) Ras2 is the major regulator of adenylate cyclase, while Ras1 is only a minor one. 
Accordingly, ras2∆ mutants present low levels of intracellular cAMP [87]; 
b) ras2∆ mutants are defective for growth on non-fermentable carbon sources [80], 
however this growth defect can be suppressed by overproduction of the RAS1 gene 
product [82];  
c) ras1∆ mutants with a further temperature-sensitive RAS2 mutation, accumulate 
unbudded cells at non-permissive temperatures because they arrest at G1 phase 
[42];  
d) ras2∆ras2∆ diploids an increase in storage carbohydrates, sporulation and an high 
heat shock resistance was observed, even in rich medium. On the contrary, an 
activating mutation of RAS2 such as RAS2Val19, causes a reduction of the glycogen 
storage level, and an increase in sensitivity to nutrient starvation and to heat shock 
[42, 51, 88];  
e) ras2∆ have increased longevity and resistance to oxidative stress [89];  
f) strains carrying hypo-active RAS2 alleles exhibit a delay in recovery from glucose 
starvation [90].  
 
1.3.2 RAS/cAMP/PKA signalling pathway 
Similar to the mammalian cells, in the yeast S. cerevisiae RAS pathway is activated 
by growth signals, importantly glucose [91]. In S. cerevisiae, Ras proteins connect 
nutrient availability to cell growth through regulation of PKA activity, being thus an 
element of cAMP/PKA pathway [92] as above mentioned. RAS/cAMP/PKA is involved 
in cell adaptation to environmental changes, responding to nutrient status and various 
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types of stress, such as, oxidative, osmotic and heat shock stresses [28]. 
RAS/cAMP/PKA pathway performs a key role in the modulation of growth, metabolism, 
aging, stress resistance, morphogenesis (stimulates filamentous and invasive growth), 
and cell cycle progression, to ensure that growth occurs only when overall conditions 
are favourable [36, 42, 92]. This pathway negatively regulates cellular physiology 
characteristic of stationary phase/nutrient starvation. Consistently, cells with 
constitutive RAS/cAMP/PKA signalling fail to adapt their growth program in response to 
nutrient starvation and rapidly lose viability [93]. 
Ras1 and Ras2 are two small monomeric GTP-binding proteins capable to 
switch between an active GTP-bound state and an inactive GDP-bound form. In yeast 
as in mammals, the guanine adenosine phosphate (GAPs) encoded by IRA1 and IRA2 
in yeast, down-regulate Ras1 and Ras2 through GTP hydrolysis, resulting in the 
accumulation of the inactive Ras protein form. Otherwise, the Cdc25 and Sdc25 GEFs 
promote GDP re-charging to GTP. When Ras1 and Ras2 are in their active 
conformation (phosphorylated), their hyper-variable domain binds directly to the 
adenylate cyclase (Cyr1p), which is the only RAS effector protein identified in S. 
cerevisiae and the main component of this signalling transduction pathway (Fig. 5-8) 
[92]. Cyr1 catalyses the synthesis of cAMP, that binds to the regulatory subunit of the 
PKA (Bcy1p) triggering the PKA activity by inducing its dissociation from the PKA 
catalytic subunits (encoded by TPK1, TPK2, and TPK3) [94]. In turn, PKA signals to the 
nucleus to carry out many functions of which the essential one is G1 cell cycle 
progression [95]. Ras proteins are required to maintain basal adenylate cyclase 
activity, being thus essential for cell viability [36, 73]. 
The constitutive activation of the RAS/cAMP/PKA pathway prevents several 
rapamycin-induced TOR responses, such as the nuclear translocation of the 
transcription factor Msn2 and the consequent induction of stress genes, the 
accumulation of storage carbohydrates, the induction of autophagy, and the down-
regulation of ribosome biogenesis [93]. The constitutive activation of the RAS pathway 
also can suppress a TOR deficiency [93]. Moreover, many of TOR-mediated responses 
are signalled through the RAS/cAMP/PKA pathway, independently of TOR effectors, 
and acting upstream of Ras proteins to regulate the PKA activity [36] (Fig. 7, 8). This 
relationship between these two pathways could go as far as suggesting RAS pathway 
as a novel TOR effector branch [93]. This is emphasised by the fact that enhanced 
sensitivity to rapamycin is often a result of the hyperactivation of RAS/cAMP/PKA 
signalling [96]. 
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1.3.2.1 RAS/cAMP/PKA pathway in response to different stresses 
Many pathways, including the RAS/cAMP/PKA pathway, converge on the related 
transcription factors Msn2 and Msn4, which induce stress genes in response to a wide 
variety of environmental conditions including nutritional, osmotic, acidic, heat shock 
and oxidative stresses, as well as diauxic transition [31, 38].  
The RAS/cAMP/PKA pathway is a negative regulator of the these stress response 
pathway genes, once in optimal growth conditions, RAS/cAMP/PKA pathway is 
activated and repress the function of the general stress transcription factor Msn2/Msn4 
[97], also negatively regulating the Msn2/Msn4 nuclear localization, which is mandatory 
under stress condition [38, 40]. On the contrary, the nutrient starvation, oxidative 
stress, heat shock and entry into stationary phase demand RAS/cAMP/PKA repression 
[56]. In S. cerevisiae, the RAS/cAMP/PKA pathway must be shut down to allow cell 
cycle exit, and a full stress response [98]. Concurrently, mutants with high PKA activity 
display a low tolerance to stress usually associated to optimal growth conditions, while 
mutants with low PKA activity have high stress tolerance, which in turn is related to 
suboptimal growth conditions [40]. 
As above mentioned, in response to oxidative stress, CWI/PKC, TOR and 
RAS/cAMP/PKA pathways crosstalk through Rom2/Rho1 (Fig. 7). Two possible models 
were proposed to this crosstalk: (a) Rho1p signals simultaneously but independently of 
Tor1 and Ras2 inactivation; and (b) Rho1 first inactivates Tor1 protein and then this 
transmits the signal to inhibit Ras2. Moreover, crosstalk also occurs in a reverse flow, 
from TOR and RAS to the CWI/PKC pathway. In this case the signal flows from Ras2 
and Tor1 inactivation to induce the phosphorylation of Slt2, activating the CWI/PKC 
pathway in the absence of the Mtl1 protein, assuring the proper adaptive response to 
oxidative and glucose deprivation [38, 56]. In addition, the hyperactivation of 
RAS/cAMP/PKA pathway decreases the cell tolerance to various stress conditions, 
including wall-damaging high-temperature [99-102].  
 
1.3.2.2 RAS/cAMP/PKA pathway in filamentous growth 
Ras proteins are central regulators, activators of the two pathways involved in the 
filamentous growth response [23, 26]. However, Ras1 and Ras2 have distinct 
importance in the regulation of invasive growth: 
a) Ras2, not Ras1, appears to be the central element of the morphogenetic switch;  
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b) RAS2 is needed to induce invasive growth, since RAS1 expression in a ras2∆ 
mutant allows growth but not invasive growth;  
c) The expression of specific RAS2 alleles can uncouple the two effectors pathways; 
d) The loss of RAS2 prevents invasion, while the hyperactivation of RAS pathway by 
integration of the RAS2V19 allele, causes hyperfilamentation. 
The activation of Ras2-dependent pathway is therefore required for filamentous 
growth [22, 23, 26]. Ras2 activates invasive growth using either of two downstream 
signalling pathways, the filamentation MAPK (Cdc42p/Ste20p/MAPK) cascade or the 
cAMP dependent protein kinase (Cyr1p/cAMP/PKA) pathway, which were above 
mentioned [22, 23, 26]. Surprisingly, although Ras2 has been placed upstream of 
pathways responsible for the morphogenetic switch, there is at present no information 
on the mechanisms by which Ras2 might act. Ras2 activity also decreases the activity 
of the stress responsive transcription factors Msn2p and Msn4p by an overactive 
Ras2/cAMP/PKA cascade, which is essential for invasive growth phenotype [91]. In 
addition, Ras2 is also involved in the yeast life span [26].  
 
1.3.2.3 RAS/cAMP/PKA pathway in cellular aging  
In fact, Ras2 downstream pathway has been argued to be a key regulator of aging 
in yeast, and to share similarities with the insulin/IGF1-(like) longevity pathway of 
mammals [27]. RAS constitutes a pro-aging pathway, negatively regulating the 
longevity. Mutations that decrease the activity of the RAS/Cyr1/PKA pathway extend 
longevity and increase stress resistance by activating the above-mentioned 
transcription factors Msn2/Msn4 (Fig. 8) [103, 104]. It is also remarkable that mutation 
or overexpression of several other components of the PKA cascade like RAS1, 
CDC25, CYR1 affect lifespan, suggesting that in fact, this pathway modulates the life 
span [105].  
RAS1 and RAS2 show opposite roles in replicative aging. The deletion of RAS1 
extends, whereas the deletion of RAS2 shortens replicative longevity, in turn the 
induced expression of the RAS2 extends, while the overexpression of RAS1 does not 
affect replicative longevity [87] [51]. Moreover, RAS genes also play opposite roles in 
the regulation of CLS. The deletion of RAS2 causes CLS extension, while the 
constitutive activation of RAS signalling pathway (e.g. RAS2val19) causes a decrease of 
CLS [27]. These opposite effects show that the two aging models are somehow 
related, but that at the same time each has particular characteristics [44].  
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1.3.2.4 The expression of human Ras isoforms in S. cerevisiae  
S. cerevisiae has been use as model system to study mammalian RAS genes via 
expression of their correspondent cDNAs in strains deleted for either yeast RAS gene. 
The mammalian HRAS cDNA was expressed for the first time in yeast using a clever 
construction strategy that enabled the deletion of both yeast RAS genes without the 
yeast losing viability [106]. Reversely, a modified RAS1 transformed NIH-3T3 cells 
[107]. The functional interchangeability between yeast and mammalian RAS genes [42] 
indicates a profound conservation not only of the amino acid sequence, but also of 
detailed biological function. 
 
1.4 Rationale and aims of the present work 
This master thesis was develop within the scope of Glycopharm - Marie Curie Initial 
Training Network, which scientific objectives are: the development and testing of 
selective galectin-blocking compounds and the development and testing of galectin-
mimetic peptides with respective target selectivity. This project impacts enormously on 
a wide variety of diseases in need for novel therapeutic solutions, namely through the 
aim of developing a rapid and easy-to-use tool for primary pharmacological testing. 
This thesis is enclose in the wide objectives of the network and aims at building and 
validating a high throughput-screening platform of yeast strains displaying phenotypes 
that can enable the survey of putative galectin-related ligands/inhibitors. This platform 
was designed to consist of two types of strains, the ones expressing tout court human 
galectins (in particular Gal3 and Gal1), and the ones expressing these human proteins 
together with the human KRASwt cDNA. An additional set of yeast strains expressing 
KRASwt without galectin will also be use, in order to study the effect of KRASwt alone 
and compare it with the effect resulting from the co-expression of KRASwt and 
galectins. The rationale behind this relates with the putative dialogue between galectins 
and RAS signalling pathway in mammals.  
RAS1 and RAS2 genes encode low molecular weight, GTP-binding/hydrolysing 
proteins that are highly conserved throughout all eukaryotic species [108]. In human 
cells, the RAS proto-oncogenes encode proteins that are involved in the control of cell 
growth, differentiation and survival, having thus a potential role in cancer development 
[109]. In humans as in S. cerevisiae, Ras proteins are signal switch molecules that 
regulate cell fates by coupling receptor activation to downstream effector pathways that 
control diverse cellular responses including proliferation and survival [42, 110, 111]. 
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Beyond the protein structural similarities, also the genes from both organisms are 
functionally homologous and carry out similar functions [112]. Among all human RAS 
genes, KRAS is expressed in most cellular types, and is the one most frequently 
mutated in diverse types of cancer [110].  
S. cerevisiae harbours one functional RAS pathway, mediated by RAS1 and RAS2 
genes [113]. RAS signalling in yeast controls similar biological processes as in higher 
eukaryotes in response to environmental changes, namely cell proliferation, growth, 
metabolism, aging, morphogenesis, and cell cycle progression [42]. This functional 
conservation allows the use of yeast as a model organism to study mammalian 
proteins and molecular processes [5], including RAS signalling [108]. Moreover, in the 
last decades, the yeast S. cerevisiae has been identified as a powerful tool to study the 
relationship between genotype and phenotype in eukaryotic cells, due to an easy 
experimental tractability, allowing inference of individual gene functions or of network 
structures through various kinds of experiments [5]. 
The principal aim of this thesis was the construction of KRASwt expressing strains 
of S. cerevisiae, and the subsequent phenotype screening, as part of the development 
of a yeast-based phenotypic platform for future pharmacological testing. Human 
KRASwt cDNA will be express in S. cerevisiae BY4741 genetic background deleted for 
RAS1 and RAS2. This genetic background was chosen according with the genetic 
marks availability, and for phenotyping control identical strains from the W303-1A 
background (also haploid and from the same mating type - a) will be used (Brito A.S., 
unpublished work). 
The subsequent phenotypic characterization of the KRASwt expressing strains will 
focus on assaying growth-influencing conditions, like carbon source, temperature, pH 
and different types of environmental stress, as well as proliferation, chronological 
aging, cell cycle progression and haploid invasive growth. The data to be obtain are 
expect to contribute to gain insight into the heterologous expression of KRAS in yeasts 
to allow the future utilization of the above-mentioned platform. The results of this thesis 
will be complemented with identically obtained phenotypes using BY4741 harbouring 
the chromosomal insertion of KRASwt (Cazzanelli J., unpublished work), and using the 
control strains from S. cerevisiae W303-1A background, (Brito A.S., unpublished work). 
Altogether, this data will serve for the development of the yeast-based high throughput 
phenotype platform. This knowledge is expect to be subsequently validated in human 
derived cell lines, paving the way for the utilization of the platform in the development 
of new diagnostic/prognostic tests and new bioactive ligands/inhibitors.
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2. Material and Methods 
2.1 Strains and growth conditions 
The Saccharomyces cerevisiae and Escherichia coli strains used in this work are 
listed on Table 1. E. coli XL1-Blue strain was used for plasmid propagation. 
 
Table 1. The S. cerevisiae BY4741 and E.coli strains used in present work. 
Strains Genotype Origin 
BY4741 
BY4741 ras1∆ 
BY4741 ras2∆ 
BY4741 p426GPD 
MATa; his3∆1; leu2∆0; met15∆0; ura3∆0 
MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YOR101w::kanMX4 
MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YNL098c::kanMX4 
MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
p426GPD (URA2) 
Euroscarf single deletion 
strain collection 
Euroscarf single deletion 
strain collection 
Euroscarf single deletion 
strain collection 
this study 
BY4741 ras1∆ p426GPD MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YOR101w::kanMX4; p426GPD (URA2) 
this study 
BY4741 ras2∆ p426GPD MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YNL098c::kanMX4; p426GPD (URA2) 
this study 
BY4741 KRASwt MATa; his3∆1; leu2∆0; met15∆0; ura3∆0 this study 
BY4741 ras1∆ KRASwt MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YOR101w::kanMX4; p426GPD/KRASwt (URA2) 
this study 
BY4741 ras2∆ KRASwt 
E.coli XL1-Blue 
 
MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YNL098c::kanMX4; p426GPD/KRASwt (URA2) 
endA1 gyrA96(nalR) thi-1 recA1 relA1 lac 
glnV44 F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] 
hsdR17(rK- mK+) 
this study 
Department of Biology 
Minho University 
 
Yeast strains were grown and maintained in rich medium (YPD - yeast extract 
(1% w/v), peptone (2% w/v), glucose (2%, w/v)) or in minimal medium (YNB – yeast 
nitrogen base without amino acids and ammonium sulphate (0.17% w/v) [Difco], 
glucose (2% w/v), ammonium sulphate (0.5% w/v)). When appropriate, YNB was 
supplemented with adequate quantities of amino acids for auxotrophic 
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complementation (0.1 g/l leucine, 0.02 g/l histidine, 0.02 g/l methionine and 0.02 g/l 
uracil). All strains were batch-grown aerobically in liquid medium, at 30 ºC with orbital 
shaking at 200 rpm and air/liquid ratio of 3/1. The strains maintenance was done in 
solid medium (YNB or YPD supplemented with 2% agar), grown at 30 ºC until colonies 
were observed, and then kept at 4 ºC. 
Bacterial cells were grown in liquid Luria-Bertani (LB) medium (yeast extract (0.5%, 
w/v); tryptone (1%, w/v); NaCl (1%, w/v)), overnight at 37 ºC with shaking at 200 rpm in 
an orbital shaker. Strains were maintained in LB medium supplemented with 2% agar, 
previously grown overnight at 37 ºC and kept/storage at 4 ºC. For the selection of 
transformants, LB was supplemented with 100 µg/ml ampicillin. 
 
2.2 Plasmids 
Two plasmids, p416GPD and p426GPD [114], were used in this work to clone 
human KRASwt (Fig. 10). These are episomal shuttle plasmids, containing the strong 
GPD promoter and selective marks for yeast (uracil) and bacteria (ampicillin). p416 is 
centromeric, while p426 harbours the 2µ element and produces 10-30 copies/cell. Both 
plasmids have their multicloning site (MCS) adjacent to a strong promoter (originating 
from GPD1), and have an identical terminator (originating from CYC1). The pUC19 
vector was used as a positive control of E. coli transformation, serving to quantify the 
competence of E. coli cells. The cDNA from human KRASwt was received in a 
pLenti/KRASwt plasmid, provided by IPO-Porto. 
 
Figure 10. Schematic representation of p416GPD and p426GPD expression plasmids. 
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2.3 Preparation of E. coli competent cells  
Competent cells of E.coli XL1-Blue strain were prepared using CaCl2 (calcium 
chloride) and MgCl2 (magnesium chloride), as previously described [115]. Briefly, cells 
were inoculated in 100 ml LB and cultivated at 37 ºC and 200 rpm for 4 hours (O.D600 of 
0.6). The culture was chilled in ice for 10 min. Cells were collected by centrifugation at 
4 000 rpm (Sigma 4-16K) and 4 ºC for 10 min. Supernatant was discarded and the 
pellet resuspended in 20 ml of 0.1 M MgCl2, followed by an identical centrifugation. The 
pellet was gently resuspended in 2 ml of 0.1 M CaCl2 and incubated on ice for 2 hours, 
and finally distributed by 200 ȝl aliquots. Dimethyl sulfoxide (DMSO) was added at 7% 
(v/v) final concentration, and the cells were frozen in liquid nitrogen and storage at -80 
ºC. 
 
2.4 Polymerase chain reaction (PCR) 
KRASwt gene inserted in pLenti plasmid, was amplified by PCR using the primers 
listed on Table 2. The primers were designed to include the HindIII and XhoI restriction 
sites to enable the cloning. The PCR reaction mix contained: 1X Taq reaction buffer 
(Fermentas), 0.2 mM dNTPs (deoxynucleotide triphosphates) (Biology Dept. of Minho 
University), 2 mM MgCl2 (Fermentas), 0.2 ȝM of each primer (Eurofins Genomic), 200 
ng DNA template (pLenti/KRASwt), 1.25 units/ 50 µl PCR of Taq DNA polimerase 
(Biology Dept. of Minho University) and ultrapure autoclaved water up to 20 ȝl final 
volume. As negative amplification control, a PCR reaction mixture without DNA 
template was used. Amplifications were made in PCR T100 Thermal Cycler (Biorad) all 
following the program: initial denaturation at 94 ºC for 5 min; 35 cycles of denaturation 
at 94 ºC for 30 sec, primers annealing at 55 ºC for 30 sec and extension at 68 ºC for 90 
sec, and a final elongation step at 72 ºC for 10 min. To confirm the KRASwt 
amplification, the PCR products were analysed by electrophoresis in 1% (w/v) agarose 
gel, pre-stained with 2 µl of gel red (Biotium). 
 
2.5 DNA electrophoresis in agarose gel 
Agarose gels for DNA electrophoresis were prepared with 50 ml of TAE 1X buffer 
(1l of TAE 50X; 242g of Tris base, 57.1 ml of glacial acetic acid and 100 ml of 0.5 M 
EDTA (pH 8)) to a final concentration of 1% agarose. 2 µl of Gel Red (Biotium) dye was 
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used for gel pre-staining. Each 3-5 ȝl DNA sample was added 5 ȝl DNA loading buffer 
6X (100 ml: 0,125 mg of bromofenol blue, 0.125 mg of Xylene cyanol, 12 ml 0.5 M 
EDTA [pH 8,0], and 30 ml of glycerol). 2 µl of DNA molecular ladder Ȝ DNA/Eco-471 
(MBI Fermentas) was used as reference. The electrophoresis performed in a Mini-
SubCell GT (BioRad) system. The gel run in TAE 1X buffer at 75-100 V. The DNA 
visualized by UV illumination (245 nm) at UV- transilluminator GenoSmart (VWR). The 
extraction and purification of DNA fragments from agarose gel electrophoresis was 
done using GenElute Gel Extraction Kit (Sigma Aldrich), following the protocol of the 
manufacturer. 
 
Table 2. Primers used for amplification of human KRASwt fragment. 
Primer Primer sequence (5´- 3’) Commentary 
FW_11044 KRAS GCG AAG CTT ATG ACT GAA TAT AAA 
CTT GTG GTA GTT GGA 
Includes the HindIII restriction 
site (A^AGCTT) 
RV_11044 KRAS GCG CTC GAG CAT AAT TAC ACA CTT 
TGT CTT TGA CTT CTT 
Includes the XhoI restriction site 
(C^TCGAG) 
 
2.6 DNA enzymatic digestion and ligation 
Each restriction mixture contained: 300 ng of human KRASwt cDNA (amplified by 
PCR) to be digested or 300 ng of either p416 or p426 vectors, 1X buffer R 
(Fermentas), 1X HindIII (Fermentas), 1X XhoI (Fermentas), and ultrapure water till 
complete the final 20 µl volume. The ratio of volumes for this mixture was calculated 
using the Fermentas double digestion tool (http://www.fermentas.com/en/tools/doubledigest). 
The appropriate buffer for the enzyme was checked in the correspondent company 
webpage devoted to enzyme/buffer compatibility. Digestion was allowed to occur for 4 
hours at 37 ºC after which the enzymes were inactivated by heating at 75 ºC for 20 
min. The final products of digestions were verify by DNA electrophoresis as described 
above. The ligation reaction mix contained: 20 ng of vector, 100 ng of insert, 2X T4 
DNA ligase buffer (Roche), 5U of T4 DNA ligase (Roche) and ultrapure water up to the 
final volume of 20 ȝl. All ligations were allowed to occur overnight at room temperature.  
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2.7 Transformation of E.coli and plasmid extraction 
The transformation of E. coli XL1-Blue competent cells with plasmid DNA was 
made following the heat shock method as previously described [116]. Transformants 
selection was performed based on ampicillin resistance. Approximately 200 ng of 
plasmid DNA was added to 200 ȝl of competent cells and maintained on ice for 40 
minutes. This was subject to a 2 min heat shock at 42 ºC, followed again by 2 min 
cooling on ice. In order to allow cells to recover, 500 ȝl of LB medium was added and 
the cell suspension was incubated 1 h at 37 ºC with orbital shaking at 200 rpm. 
Volumes of 100 ȝl and 300 ȝl of each transformation mixture, were platted on selective 
medium (solid LB medium supplemented with 100 ȝg/ml of ampicillin). Cells were 
allowed to grow overnight at 37 ºC.  
In order to extract plasmid DNA, E. coli XL1Blue transformed cells were inoculated 
in 5 ml of LB medium with ampicillin (100 ȝg/ml) and incubated overnight at 37 °C with 
200 rpm orbital shaking. DNA extraction was performed using the 
GenElutePlasmidMiniprep kit (Sigma-Aldrich), according to the manufacturer 
instructions. The integrity of plasmid DNA was verify by double enzymatic digestion, 
with the restriction enzymes HindIII and XhoI, and a subsequent DNA electrophoresis 
in 1% (w/v) agarose gel. 
 
2.8 Transformation of S. cerevisiae and verification by PCR 
S. cerevisiae was transformed by the lithium acetate method, as previously 
described [116]. Cells were cultured overnight at 30 ºC in 5 ml of YPD with 200 rpm 
orbital shaking up to O.D600 = 1. The cells were collected by centrifugation during 5 min 
at 3 000 rpm (Sigma 4-16K), washed twice with sterile deionized water and one with 
LiAc (0.1 M)/ TE (1X) for 2 min at 8 000 rpm (miniSpin, Eppendorf). The pellet was 
resuspended in 200 µl of LiAc (0.1 M)/ TE (1X) and placed at 4º C overnight. Each 
transformation mix was prepared with 100 µl of yeast competent cells, 20 µl of ssDNA 
carrier (2.5 mg/ml) (Sigma), pre-heated at 90 ºC during 5 min, 600 µl of LiAc (0.1 M)/TE 
(1x) – PEG 50%, and ~0.2 µg of plasmid DNA (except for the negative control). The 
cells were incubated at 30 ºC with orbital shaking during ~1 h, then submitted to a 15 
min heat shock at 42 ºC and placed at 4 ºC for 10 min. The cells were harvested by 
centrifugation, 2 min at 8 000 rpm (miniSpin, Eppendorf), ressuspended in 200 µl of 
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sterile deionized water. The cellular suspension was plated on selective medium, YNB 
URA-, and incubated at 30 ºC until colonies appeared (around 3 days). 
The verification of yeast transformants was done by PCR. Individual colonies grown 
on selective medium were picked and streaked onto a new plate of YNB URA- and 
incubated 2 days at 30 ºC. For DNA extraction and precipitation, yeast biomass was 
picked from the selective medium plate, suspended in 100 µl of 200 mM LiAc/ 1% SDS 
solution and incubated for 5min at 70 ºC. After adding 300 µl of 100% ethanol and 
vortexing, the mixture of DNA and cell debris was spun down at 15 000 rpm (Sigma 4-
16K) for 3 min. The pellet was washed with 70% ethanol, dissolved in 100 µl of 
ultrapure water, and cell debris was again spun down at 15 000 rpm (Sigma 4-16K) for 
15sec. PCR reaction was done using 1 µl of the obtained supernatant, and it was 
performed as described above. The PCR products were checked by agarose gel 
electrophoresis. 
 
2.9 Western Blot analysis 
2.9.1 Yeast protein extraction and precipitation 
For Western Blot (WB) analysis, yeast cell proteins were extracted using the 
trichloroacetic acid (TCA) method. Cells were grown in 5 ml YNB, supplemented with 
respective amino acids when appropriate, at 30 ºC and 200 rpm until mid-exponential 
phase. Cultures were diluted to OD600= 1 and cells were collected by centrifugation at 4 
000 rpm (miniSpin, Eppendorf) for 5 min. When necessary the pellet was stored at -20 
ºC. The pellet, was ressuspended in 200 µl of 0.2 M NaOH/2% β-mercaptoethanol and 
incubated at 4 ºC for 10 min. 400 µl of 20% TCA was added to each tube and 
incubated on ice for 10 min. Cells were harvested by centrifugation, at 13 000 rpm 
(minispin, Eppendorf) during 5 min, the pellet was washed with 500 µl cold acetone and 
again collected by identical centrifugation. Acetone was completely removed by 
evaporation, and the pellet resuspended in 100 µl of Laemmli buffer 2X (SDS 4%, 120 
mM Tris HCl, 20% glycerol, 0.1% bromophenol blue) with 3 µl of DTT 0.01 M. Protein 
suspensions were stored at -20 ºC. 
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2.9.2 SDS-PAGE (Sodium Dodecyl Sulphate – Polyacrylamide 
Gel Electrophoresis) 
Polyacrylamide gels were prepared at 15% (w/v) for resolution gel, and 5% (w/v) for 
concentration gel. Prior to gel loading the protein extracts were denatured at 95 ºC 
during 10 min, and 10 µl of each total protein extract sample was loaded per well. 
NZYColour Protein Marker II (Nzytech) (2 µl) was used as reference. The gels were 
inserted into the electrophoresis tank and submerged with Running Buffer (19.2 mM 
glycin, 2.5 mM Tris base, 0.01% SDS). Electrophoresis was performed in Mini Protean 
Tetra Cell I system (BioRad), at 20 mA. 
 
2.9.3 Western Blot assay 
SDS-PAGE gels were electro blotted onto PVDF membrane (Roche) in a Trans-
Blot Electrophoretic Transfer Cell System (BioRad) immersed in a transfer buffer (19.2 
mM glycin, 2.5 mM Tris, 20% ethanol, 0.05% SDS, pH 8.3) at 1mA/cm2 of membrane, 
during 90 min. Membrane was blocked in 5% of blocking agent (GE Healthcare), 
dissolved in TBST (TBS 10X (Tris-base; NaCl ) pH 7.5 and 0.1% Tween 20) and 
incubated overnight at 4 ºC with gentle rotation, in a roller mixer SRT1 equipment 
(Stuart®). The membrane was subsequently incubated in 5% blocking agent containing 
primary antibody anti-KRAS (Sigma) at dilution 1:1000, during 1 hour at room 
temperature with mild agitation in a roller mixer SRT1 equipment (Stuart). To remove 
the excess of primary antibody, the membrane was washed 3 times with TBST, 5 min 
each. The incubation with the secondary antibody - rabbit anti-mouse IgG conjugated 
to horseradish peroxidase (HRP) (Sigma) - at dilution 1:10 000, for 1 hour at room 
temperature and mild agitation. The membrane was washed 6 times with TBST, 10 min 
each. HRP conjugated rabbit anti-mouse IgG was detected with ECL Plus Western 
Blotting Detection system (Amersham Biosciences) and the result was visualized in a 
ChemiDoc XRS image analysis system (BioRad Laboratories Inc.). 
 
2.10 Phenotype Screening 
2.10.1 Growth parameters in yeast batch cultures 
Overnight yeast cultures grown were diluted to an OD600 of 0.1, and used to 
incubate fresh YNB batch cultures. Incubation was performed at 30 ºC, in an orbital 
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shaker (200 rpm), with an air/liquid ratio of 3:1. Growth was monitored 
spectrophotometrically (OD600nm) in a Spectrophotometer Genesis 20 (Thermo 
Spectronic), every 2 hours up to ±30 h. Specific growth rate was calculated within the 
logarithmic growth part of the curve.  
 
2.10.2 Growth assays in solid medium 
To test sensibility/ resistance to different types of stress, as also growth in different 
carbon sources, drop tests assays were performed. Inoculum consisted of overnight 
YNB cultures at OD600 =1, containing approximately 1×107 cells/ml. Four serial dilutions 
of 1:10 (5 µl of each) were plated. Media are listed in Table 3. Results were score after 
48 h incubation at 30 °C or other (Table 3). In some exceptional cases, results were 
just visible after a longer incubation period – mentioned in the Results. Plates were 
photographed in a ChemiDoc XRS image analysis system (BioRad Laboratories Inc.).  
 
Table 3. Growth conditions tested using YNB as base-medium. 
 
Carbon sources 
 2% glucose (optimal - control) 
 2% ethanol 
 2% glycerol 
pH   pH 6 (optimal - control) 
 pH 4 
 pH 7 
High temperature stress  30ºC (optimal - control) 
 37ºC 
Oxidative stress  0.5 mM 
 1 mM  
 2 mM 
High osmotic stress  0.5 M NaCl     (0.980 aw) 
 1 M NaCl        (0.965 aw) 
 1 M Sorbitol    (0.980 aw) 
 1.5 M Sorbitol (0.97 aw) 
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2.10.3 Adherence to agar and Invasion 
Exponential YNB cultures were diluted to an O.D600 =1, and 200 µl were spotted 
onto YNB without glucose, glucose absence induce the filamentous invasive growth 
[25]. Controls were performed in YNB with 2% (w/v) glucose. Cells were allowed to 
grow at 30 ºC for 7 and 20 days. Adhesion to agar was tested washing the plates in 
running water with constant pressure during 30 sec, adapted from [33]. Plates were 
visualized and photographed in a ChemiDoc XRS image analysis system (BioRad 
Laboratories Inc.), before and after washing. The invasion capacity was inspected, the 
agar plates were subsequently cut longitudinally and the slice was inspected for 
invasive growth and photographed in a stereo microscope (Leica EZ4HD). Images 
were processed with LAS AF Leica Microsystems software. 
 
2.10.4 Filamentous growth 
Filamentous growth was observed according to the previous described [25], and 
adapted by [117]. Exponential YNB cultures were diluted and used to inoculate either 
liquid or solid medium. These were incubated at 30 ºC in filamentous growth-inducing 
condition YNB without glucose [25]. Controls were performed in YNB with 2% (w/v) 
glucose.  
Liquid medium: Overnight cultures were diluted to an OD600 of 0.2, and incubated at 
30 ºC with orbital shaking at 200 rpm during 5 days. At several time points, 10 ȝl of the 
suspension was collected, observed by light microscopy and photographed (see 
below).  
Solid medium: Cultures were inoculated using identical inoculum and were allowed 
to grow for 1-3 weeks. After washing assay, cells were collected with a loop and placed 
on microscopic slide with 10 ȝl of deionized water visualized by light microscopy and 
photographed. Microscopy assessment was done in a Leica Microsystems DM-5000B 
epifluorescence microscope with appropriate filter settings and using a 40x objective. 
Images were acquired by a Leica DCF350FX digital camera and processed with LAS 
AF Leica Microsystems software. 
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2.10.5 Chronological aging assay 
Chronological aging was tested using the methodology adapted from [118]. 
Overnight cultures on YNB were used to start 80 ml YNB batch cultures at OD600nm of 
0.1. Cells were allowed to grow for 48 h. This time-point was considered as a measure 
of 100% culture survival - T0. Cell viability was quantified by Colony Forming Units 
(CFU) in YPD during 13 further incubation days. For CFU assay, cells were counted on 
a Neubauer chamber and diluted in PBS (137 mM NaCl, 2.7 mM , 10 mM Na2HPO4, 
1.8 mM KH2PO4) to achieve ~100 cells in 240 µl [118]. Six drops (~100 cells) of 40 µl 
each were plated on YPD medium per time sample and incubated at 30 °C for 48 h. 
Colonies formed were counted. 
 
2.10.6 Cell cycle analysis  
Cell cycle analysis was performed at different growth phases (exponential and late-
stationary) and the cell treatment was adapted from [119]. For each assay, 500 µl of 
cells (±106 cell/mL) were fixed overnight in 500 µl of 70% ethanol. The cells were then 
collected by centrifugation at 13 000 rpm (minispin, Eppendorf), during 2min, and 
washed 1x in 1 mL of 50 mM sodium citrate buffer at pH 7.5. After a new identical 
centrifugation, the pellet was resuspended in 400 µl of RNase A (2mg/mL in Tris-
EDTA, pH 8.0) and incubated overnight at 37 ºC. After a new centrifugation, the pellet 
was resuspended in 200 µl of proteinase K at 5mg/mL diluted in H2O (pH 7.5), and 
incubated at 37 ºC for 45 min, and again centrifuged. The pellet was resuspended 
again in 500 µl of 50 mM sodium citrate buffer at pH 7.5, added SYTOX®-Green (Life 
Tecnologies) 5 mM 100x diluted in Tris-EDTA, pH 8.0 (20µl per 100µl sample), and 
incubated overnight at 4 ºC in the dark. Finally, 600 µl of Triton X-100 (0.25% (v/v) in 
50 mM sodium citrate buffer, pH 7.5) was mixed with the sample and vortexed. The 
final mixture was briefly sonicated (High intensity ultrasonic processor GEX 400), three 
times at 30 W, 2 sec each, incubated on ice between each sonication, for the reduction 
of cellular aggregates. At least 20 000 cells from each sample were analysed in an 
Epics® XL™ (Beckman Coulter) flow cytometer, with an excitation of 4λ7 nm and an 
emission of 520 nm according to SYTOX®-Green manufacturer instructions. Flow 
cytometry data was processed using Flowing Software 2. 
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3. Results and Discussion 
3.1 Heterologous expression of human KRASwt cDNA in 
Saccharomyces cerevisiae  
In view of genetic, molecular and functional conservation, the low eukaryotic 
organism, S. cerevisiae, was been used as model to study several human cellular 
processes and the related signalling pathways [7, 8]. This is also due to the fact that S. 
cerevisae genome can be easily engineered, allowing suitable analysis and efficient 
assessment of gene products from human cells [9, 120]. S. cerevisiae has two RAS 
genes, the RAS1 and RAS2, which proteins have amino acid sequences very similar to 
the proteins encoded by the mammalian RAS proto-oncogenes, the HRAS, NRAS and 
KRAS [81]. Both in mammals and in yeast, Ras proteins are signal switch molecules 
that regulate cell fate by coupling receptor activation to downstream effector pathways 
that control several cellular responses including proliferation and survival [42, 110]. In 
S. cerevisiae, the two RAS genes are essential and their double deletion is lethal [82]. 
The proteins Ras1 and Ras2 are extremely similar small GTPases that although 
biological equivalent both differ in the expression pattern under different physiological 
conditions [86]. In humans, the RAS isoforms (HRas, NRas a KRas) are also very 
similar to each other at sequence / structural level, but not functionally, since they 
generate different signal outputs [70]. From all RAS isoforms, KRAS is the more 
ubiquitously expressed, and it is essential for normal cellular development of many cell 
types [64]. The similarity between amino acid sequence of RAS in yeast and in 
mammals suggests homology at functional level [112]. This could enable the utilization 
of yeasts as genetic and molecular models for the study of KRAS expression. For this 
reason, S. cerevisiae mutants deleted for either RAS1 or RAS2 in the genetic 
background of the EUROSCARF Collection (BY4741) were used to express the wild 
type form of the human KRAS (KRASwt) cDNA as follows.  
 
3.1.1 KRASwt plasmid harbouring construction  
Human KRASwt cDNA was initially cloned into a pair of p4X6 series plasmids, with 
different expression strength - p416 and p426 [114]. Both p416GDP and p426GPD are 
considered useful tools for cloning procedures in yeast, the only distinction between 
them is the different expression strength: p426GPD is multicopy, ensuring high 
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expression, while p416GD only produces one copy of the recombinant protein per cell 
[114].  
Human KRASwt cDNA was already inserted in a pLenti plasmid (kindly provided by 
Manuel Teixeira from IPO Research Centre - Porto). A restriction analysis was 
performed in order to select the appropriate restriction enzymes to be used during the 
cloning steps, considering the receptor plasmid MCS and the KRASwt fragment. The 
selected enzymes were HindIII and XhoI. To obtain appropriated amounts of the 
KRASwt fragment, this was amplified from pLenti/KRASwt using primers FW_11044 
KRAS and RV_11044 KRAS (Table 2), which introduced a HindIII and an XhoI 
restriction site at the 5’ and 3’ ends of the KRASwt, respectively. The gene amplification 
was confirmed by electrophoresis (Fig. 11) and the KRASwt fragment was extracted 
and purified from the gel.  
Figure 11. Electrophoretic analysis of PCR amplified fragment originating from pLenti/KRASwt (lane 1). 
Molecular weight marker: Ȝ DNA/Eco47I (Fermentas). Red box: putative amplified KRASwt. 
 
 
The purified fragment (insert) and the empty plasmid p416GPD, were double 
digested by HindIII and XhoI. The correct double digestion of the empty plasmid 
p416GPD was confirmed by electrophoresis (not shown). The insert was then ligated to 
the vector and the resultant construction, the p416GPD/KRASwt, was used to transform 
E. coli XL1-Blue competent cells for plasmid propagation. The E. coli XL1-Blue 
transformants were selected in LB medium supplemented with 100 ȝg/ml of ampicillin. 
Transformation was confirmed by choosing randomly 8 colonies for extracting the 
plasmidic DNA and digesting again with HindIII and XhoI. The expected restriction 
fragments restriction results should be two, one correspondent to the plasmid 
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p416GPD of app. 6.6 kb, and another to the KRASwt fragment of app. 560 bp. 
Electrophoresis revealed a unique band corresponding to the linearized plasmid (not 
shown).  
A second attempt was made using a different plasmid - p426GPD that has a 
higher expression level comparatively to the p416GPD. The already amplified KRASwt 
fragment was again double digested with HindIII and XhoI restriction enzymes, as well 
as the p426GPD plasmid. The p426GPD correct enzymatic digestion was confirmed by 
electrophoresis (not shown). The double digested KRASwt was then ligated to the 
double digested vector and the resultant construction was transformed in E. coli XL1-
Blue. Again, to verify the E. coli XL1-Blue positive transformants, the plasmidic DNA 
was extracted from 2 transformants and double digested with HindIII and XhoI 
restriction enzymes (Fig. 12 lanes 1-2). A band with ≈560 bp (indicated by the red 
rectangle), most likely corresponded to the KRASwt fragment. One positive clone was 
selected to extract plasmidic DNA to transform the S. cerevisiae.  
 
Figure 12. Electrophoretic analysis of the p426/KRASwt plasmid DNA extracted from E.coli XL1-Blue 
clones and double digested with HindIII and XhoI – Lanes 1 and 2. Molecular weight marker: Ȝ 
DNA/Eco-471 (Fermentas). Red box: Digested KRASwt fragment. 
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3.1.2 Transformation of S. cerevisiae BY4741 with p426/KRASwt 
Considering the purpose of evaluating the capacity of KRASwt to complement the 
yeast RAS deletions, the BY4741 strains harbouring a deleted RAS1 or RAS2, were 
used for the expression of KRASwt. The two mutants and the mother strain were 
transformed with (a) the plasmid p426GPD (empty plasmid - ø), serving as a control, 
and (b) the corresponding plasmid containing a copy of KRASwt, under control of the 
GPD constitutive promotor (p426GPD/KRASwt).  
The BY4741 wild-type (wt), ras1Δ and ras2Δ strains transformed with 
p426GPD/KRASwt, were all selected in minimal medium YNB supplemented with the 
required amino acids, except uracil – selective marker of the plasmid. Some clones of 
each transformation were selected for PCR amplification of KRASwt fragment. A sample 
of KRASwt amplified fragment from pLenti/KRASwt, was used as positive control. The 
PCR products verification by electrophoresis demonstrated the presence of the KRASwt 
corresponding band in 6 tested samples (Fig. 13 lanes 2-7). These positive 
transformants (clones containing the KRASwt) were stored at -80ºC in glycerol, and 
propagated in the solid selective medium for daily use. 
 
Figure 13. Electrophoretic analysis of PCR amplified KRASwt originating from S. cerevisiae BY4741 
transformed with the p426GPD/KRASwt: wt (lane 2 to 4), ras1∆ (lane 5) and ras2∆ (lane 6 to 7). The 
KRAS insert corresponds to a band with a molecular weight of approximately 560 pb. As a positive 
control the pLenti/KRASwt was identically amplified by PCR (lane 1). Molecular weight marker: Ȝ 
DNA/Eco47I (Fermenta). Red box: Bands corresponding to KRASwt fragment. 
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3.1.3 Confirmation of KRASwt expression in the BY4741 positive 
transformants 
The total protein extracts from one positive transformant of each recombinant 
strain, including the strains transformed with the empty p426GPD, were isolated from 
exponential young batch cultures (OD600 =1) and were analysed by Western Blot, using 
the antibody anti-KRas (see Materials and Methods). In the first attempt, the antibody 
was used at dilution of 1:500 as recommended by the fabricant, however the signal 
was too strong. A workable dilution was 1:1000 (Fig. 14). WB analysis confirmed the 
expression of KRASwt in p426GPD-derived transformants. 
 
 
Figure 14. Western Blot analysis of KRASwt expression in S. cerevisiae BY4741. Total protein extracts 
of wt (A), ras1Δ (B) and ras2Δ (C), transformed with the empty p426GPD (Ø) and p426GPD/KRASwt, 
were probed against anti-KRas antibody (Sigma). Each column shows the result of blotting positive (+) 
or negative (-) transformants. 
 
3.2 Phenotypic effects of the KRASwt expression in S. cerevisiae 
and functional complementation of the RAS genes deletion 
In S. cerevisiae, the RAS/cAMP/PKA pathway is involved in the regulation of cell 
growth and proliferation in response to several environmental and metabolic cues, 
including nutritional, osmotic, heat, acid and oxidative stresses [31, 38, 121]. In these 
conditions, RAS signalling exerts a negative regulation, since cells are less stress-
tolerant when RAS pathway is activated [56]. Moreover, although the Ras1 and Ras2 
proteins are moderately redundant at phenotypic level, the Ras2 is the main 
responsible for the cellular functions controlled by RAS pathway [87]. In order to 
elucidate the effect of expressing KRASwt in S. cerevisiae, as well as its ability to 
functionally complement the RAS1 and the RAS2 single deletions, the wt and the 
ras1∆, ras2∆ strains from the genetic background BY4741 were transformed with 
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p426GPD/KRASwt and submitted to phenotype screening. As controls, the recipient 
strains were also transformed with the empty plasmid. This way, the phenotypic 
screens were done using the recipient strains, the recipient strains transformed with the 
p426GPD/KRASwt plasmid, and transformed with p426GPD empty plasmid.  
According to the roles attributed to the RAS genes in the response to different 
environmental cues, the yeast strains were incubated in YNB with 2% glucose and the 
required amino acids, and submitted to several types of stress:  
 High temperature (37 ºC); 
 Osmotic pressure/low water activity (aw) (0.5 M and 1 M of NaCl; 1 M and 1.5 M 
of sorbitol) at 30 ºC; 
 Oxidative stress (0.5 mM, 1 mM and 2 mM H2O2) at 30 ºC; 
 pH (pH 4, pH 6, and pH 7) at 30 ºC. 
Cells were also cultured in 2% ethanol and 2% glycerol to verify their ability to grow 
under glucose derepression/respiration conditions. All these environmental conditions 
were tested by drop test assay. Additionally, the cells were also tested as to their ability 
to adhere and invade agar surface and form filaments in function of the 
presence/absence of glucose, i.e., in glucose starvation conditions. Finally, these 
strains were studied as to the ability to thrive into post-diauxic and stationary phase 
and survive, i.e., chronological aging by c.f.u. assay, as well as the distribution of cells 
through the several cell cycle-associated phases by flow cytometry. 
 
3.2.1 Stress phenotypes associated with KRASwt expression 
3.2.1.1 High-temperature stress  
RAS signalling is involved in response to high-temperature stress. Cells with a 
temperature-sensitive RAS2 deletion are blocked in G1 phase of the cell cycle and 
accumulate as unbudded cells at non-permissive temperatures [42]. Moreover, cells 
exhibiting elevated levels of PKA are sensitive to high temperatures, whereas 
attenuated PKA activity renders an otherwise wt strain more resistant to heat shock 
[122]. According to this and to the fact that the RAS pathway leads to the PKA 
activation, it can be assumed that RAS signalling should be involved in the response to 
temperature stress.  
Chapter III – Results and Discussion 
 
43 
 
The effect of KRASwt expression in the ras1Δ, ras2Δ and wt cells on the response 
to the high temperature stress (37 ºC) was tested on glucose-based minimal medium 
(Fig. 15). As control, cells were identically cultivated at 30 °C (not shown).  
 
 
Figure 15. Phenotypic evaluation of the sensitivity to high temperature of BY4741 S. cerevisiae set of 
strains expressing human KRASwt. Strains were pre-grown on YNB w/ glucose and used for drop-out 
assay (ten-fold serial dilutions, 5 µl/ drop) on YNB w/ 2% glucose and incubated for 2 days at 37 °C. 
These results are representative of independent triplicates. 
 
The obtained results show that the deletion of either yeast RAS genes had no 
effect on temperature resistance as compared to wt. The non-phenotype of the ras2Δ 
strain to high-temperature stress appears to contradict the literature, which predicted a 
growth defect caused by RAS2 deletion [42, 82, 123]. Moreover, these results were 
observed in other than BY4741 genetic backgrounds, including the diploid EG81 strain 
[82], the 112 strain [80] and DC5/6 strain [88, 124]. Compared with these strains, 
BY4741 strain genome (Table 4) harbours a mutation on MET15 that is not shared by 
any of the other strains. The putative influence of this mutation, alternative to lys2 or 
ade2 remains for the moment unknown. On this line of thought, Cohen and Engelberg 
[113] demonstrated that the leu2 mutation on the BY4741 background could influence 
the experimental results. The authors verified an effect in the auxotrophic phenotype 
using cells grown in complete synthetic medium containing all the amino acids, 
however they indicated the possibility that the leu2 deletion affects other biochemical 
and molecular activities in the cell. 
The expression of KRASwt had no effect on the observed resistance to high-
temperatures, which in view of the above is not surprising. The exception was BY4741 
wt strain (Fig. 15). This harbours three RAS alleles - human KRASwt and the 
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endogenous RAS1 and RAS2 – leading to a probably increased amount of intracellular 
Ras proteins, which could conduct to the hyperactivation of the RAS/cAMP/PKA 
pathway. This is associated with the decrease of tolerance to various stress conditions 
including thermotolerance [99-102]. This being the case, the tests on other type of 
stresses made during the present work with the same strains should yield identical 
results. 
 
3.2.1.2 High osmotic stress  
Yeast cells respond to a shift to higher osmolarity by increasing the cellular content 
of the osmolyte glycerol. In addition to the HOG pathway also RAS/cAMP/PKA has 
been shown to affect the expression of genes upon an osmotic upshift [125]. PKA 
activity influences negatively the expression of response proteins to the osmotic stress 
[125]. In addition, the ras2∆ mutants demonstrated resistance to the hyperosmolarity 
[126]. The osmotic stress can be generated by high concentrations of salts, or neutral 
solutes like sorbitol or other sugar alcohols at concentrations causing similar decrease 
in aw [40, 127]. To assess the strains sensitivity to hyperosmotic stress, NaCl was used 
at 0.5 M (0.980 aw) and 1 M (0.965 aw). Alternatively, identical aw values were produced 
using sorbitol at final concentrations of 1 M (0.980 aw) and 1.5 M (0.970 aw) [127].  
Results (Fig. 16) revealed identical results to the ones obtained with high 
temperature: all strains grew well in the presence of either NaCl or sorbitol 
concentrations, except the strain expressing the three RAS alleles – BY4741 wt 
KRASwt (Fig. 16). These results strengthen the suggestion above-mentioned of the 
difference imposed by genetic background on RAS-mediated stress responses. 
Similarly to what happened in high-temperature, the fact that ras1Δ and ras2Δ strains 
(expressing or not the KRASwt) and wt strain (not expressing KRASwt ) had no visible 
phenotype in response to osmotic stress, suggested that the stress responses in 
BY4741 background might be highly increased. 
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Figure 16. Phenotypic evaluation of the sensitivity to osmotic stress of BY4741 S. cerevisiae set of 
strains expressing human KRASwt. Strains were pre-grown on YNB w/glucose and used for drop-out 
assay (ten-fold serial dilutions, 5 µl/ drop) on YNB w/ 2% glucose with NaCl or sorbitol and incubated 
for 2 days at 30 °C. These results are representative of independent triplicates.  
 
 
3.2.1.3 Oxidative stress 
All aerobically growing organisms are continuously exposed to oxidants. Moreover, 
most reactive oxygen species (ROS) are generate as by-products during respiration. 
Oxidative stress therefore, occurs when the concentration of these oxidants increases 
beyond the antioxidant buffering capacity of the cell [128]. H2O2 is one of the most 
common reactive oxygen species. The RAS/cAMP/PKA pathway negatively affects the 
response to H2O2 stress [97, 129]. High intracellular cAMP levels induce 
hypersensitivity to H2O2 concomitant with a defective induction of H2O2 stress 
responsive genes [121]. Therefore, the RAS signal transduction pathway (responsible 
for regulating intracellular cAMP levels) is clearly important in the regulation of 
oxidative stress response [128], and mutations in RAS genes, namely the RAS2 
deletion, should increase survival and resistance to oxidative stress [89]. 
In the present work the oxidative stress response of wt, ras1Δ and ras2Δ strains, 
and further the effect of KRASwt expression, were assessed using different 
concentrations of H2O2 (0.5 mM, 1 mM and 2 mM).  
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Figure 17. Phenotypic evaluation of the sensitivity to osmotic stress of BY4741 S. cerevisiae set of 
strains expressing human KRASwt. Strains were pre-grown on YNB w/ glucose and used for drop-out 
assay (ten-fold serial dilutions, 5 µl/ drop) on YNB w/ 2% glucose and H2O2 and incubated for 3 days at 
30 °C. These results are representative of independent triplicates. 
 
As can be seen in Fig. 17, the pattern of response obtained with high temperature 
and osmotic stresses was repeated. wt and RAS mutant strains, as also the same 
strains harbouring the empty plasmid, were resistant to the presence of either 0.5 mM 
or 1 mM of H2O2. On the other hand, all the strains expressing KRASwt, were sensitive 
to 0.5 mM H2O2 but not to 1 mM H2O2, with the exception of wt expressing KRASwt, 
which was sensitive to both conditions. An additional experiment at 2 mM H2O2 killed 
all the strains (not shown).  
According to the literature, ras2∆ mutant was described as more resistant to 
oxidative stress than wt strain [27]. Once again, this was described in a totally different 
genetic background as in Table 4 - [109]. The fact that BY4741 wt strain grew as well 
as the strains deleted in RAS genes could indicate, as mentioned above, that it is due 
to the different genetic background. Still, this is not straightforward since the further 
expression of KRASwt induced sensitivity to oxidative stress, most probably an effect 
caused by the overexpression KRASwt gene leading to the hyperactivation of the RAS 
pathway above discussed. Nevertheless, as described in the Introduction, full oxidative 
stress responsive is subject to crosstalk between the CWI/PKC, RAS and TOR 
signalling pathways, as well as HOG pathway. A miss-regulation at the top part of RAS 
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pathway could influence indirectly responses to stresses that depend on all or several 
of these pathways. This remains to be seen in the future. 
 
3.2.1.4 High and low pH 
Generally, eukaryotic cells maintain their intracellular pH within a narrow range, 
despite wide variations that may occur in the extracellular pH. As the gap between the 
extracellular and the intracellular pH widens, greater stress applies to the cells and 
more energy is expended to maintain the intracellular pH within the range that permits 
growth and survival of the yeast [130]. The ability of the strains to growth on YNB 
medium at pH 4 (low pH) and at pH 7.0 (high pH) was tested. As control, the strains 
were also grown at pH 6, the optimal pH for growth. The results (not shown) clearly 
show that none of the pH values tested affected growth of any of the strains, 
suggesting that RAS genes could not important for intracellular pH homeostasis.  
 
3.2.2 Effect of KRASwt expression on growth on non-fermentable 
carbon sources 
Ras2 is expressed with roughly equal efficiency in any carbon source, whereas 
Ras1 is highly expressed on glucose and poorly expressed in non-fermentable carbon 
sources. As consequence, the ras2∆ strain is defective on non-fermentable carbon 
sources [80]. Thus, growth ability was tested on YNB medium with 2% (v/v) ethanol or 
2% (v/v) glycerol. Controls were done on minimal medium with 2% (w/v) glucose. As 
expected [80], all strains tested grew better on glucose than on glycerol or ethanol (Fig. 
18). As above, no phenotypic differences were visible between the wt and the mutant 
strains, indicating that the absence of RAS2 in BY471 did not affect the growth in non-
fermentable conditions. This result is supported by the study of Tatchell et al. [82], in 
which no phenotypic changes were observed when haploid strains containing the 
disruptions of either RAS1 or RAS2 were used. Instead, these authors found an 
impaired growth on the respiratory conditions when they used the diploid yeast cells 
with ras2-530 disrupted RAS2 allele. On the other hand, the results in Fig. 18 show that 
the expression of KRASwt affected negatively growth on ethanol or glycerol, more 
strongly in the wt strain expressing the KRASwt. This result also indicates that the 
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hyperactivation of the RAS/cAMP/PKA pathway, already mentioned, interfered with the 
yeast ability to grow on non-fermentable carbon sources [131].  
 
Figure 18. Phenotypic evaluation of the sensitivity to osmotic stress of BY4741 S. cerevisiae set of 
strains expressing human KRASwt. Strains were pre-grown on YNB w/ glucose and used for drop-out 
assay (ten-fold serial dilutions, 5 µl/ drop) on YNB w/ 2% ethanol or glycerol, or 2% glucose for control. 
Results show cultures incubated at 30 °C for 2 days in the case of glucose, and 10 days for the other 
carbon sources. These results are representative of independent triplicates. 
 
 
3.2.3 Effect of KRASwt expression in the haploid invasive growth 
Filamentous growth is a nutrient-regulated growth response. In conditions of 
nutrient limitation, S. cerevisiae haploid cells can suffer a subtle dimorphic switch, 
characterized by a slight elongation of cells, an enhanced cell-cell adhesion, and a 
change in cell polarity [25]. These modifications can culminate in the appearance of a 
filamentous form, which allows the cells a moderate penetration in agar medium 
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surface (invasive growth) [132]. RAS2/cAMP/PKA signalling is known to be required for 
filamentous growth and invasion [133]. Accordingly, previous studies demonstrated that 
the RAS2 deletion prevents invasion [23, 26]. 
Adhesion to agar and invasive growth was tested in the same yeast strains group 
as above. Cell adhesion was assessed using the standard plate washing assay [33], 
followed by inspection of agar slices for invasive growth (see materials and Methods). 
Filamentation was verified by microscopic observation of cells recovered from the 
surface of agar. These assays were done using glucose grown and starved cells. This 
is due to the previous observation that a S. cerevisiae haploid strain (L5528 – Table 4) 
was capable of invasive behaviour and filament formation while growing on glucose 
[132]. All tested strains adhered to the surface of the medium without glucose (Fig. 19).  
 
Figure 19. Assaying adherence to the agar of BY4741 S. cerevisiae set of strains expressing human 
KRASwt. Strains were pre-grown on YNB w/ glucose and equal concentrations of cells were spotted 
onto plates of YNB w/o glucose, and incubated for 7 days at 30 °C. The adherence was verified after 
washing the surface of the agar with a gentle stream of running water. These results are representative 
of triplicates. 
 
The strains expressing KRASwt presented a stronger adherence than all other, in 
particular the wt strain. This increased adherence might suggest higher invasive growth 
ability, nevertheless, none of the strains presented agar invasion (not shown). 
Filamentous growth also did not occur in any of the strains (not shown). These results, 
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with the exception of the invasion phenotype, were confirmed in longer incubation 
periods (up to 3 weeks), and in glucose growing cells (not shown). Due to the RAS2 
expression (in the wt and ras1∆ strains), it was expected that these strains displayed 
filamentous and invasive behaviour. However, this is not unexpected considering that 
BY4741 background derives from S288C, which is defective in Flo8p, a protein 
required for filamentous growth [134, 135].  
The expression of the KRASwt in the wt and ras1∆ mutant strains did not change 
the non-invasive phenotype of these strains on glucose-based medium. On the 
contrary, the expression of KRASwt in the ras2∆ strain led to an invasive phenotype 
(Fig. 20 – Panel I). Nevertheless, this invasive pattern did not present filaments as 
expected, but rather a cellular mass growing deep into agar. In the literature, some 
other haploid mutant strains, namely bud1, bud2, and bud5, were shown unable to 
form filaments but still penetrating agar in a similar fashion [132]. 
Figure 20. Assaying agar invasion of BY4741 S. cerevisiae set of strains expressing human KRASwt: 
wt (A); ras1∆ (B); ras2∆ (C); wt p426ø (D); ras1∆ p426ø (E); ras2∆ p426ø (F); wt KRASwt (G); ras1∆ 
KRASwt (H) and ras2∆ KRASwt (I). Assays were performed as in Fig.19 except that plates were 
incubated for 3 weeks. Agar was sliced with a scalpel, and sections were set perpendicular to the plan 
of invasion for visualization.  
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Table 4: Compared genetic backgrounds of BY4741 and the different strains used in the literature to 
describe Ras-related phenotypes. 
Strain Genetic background              
BY4741 MATa leu2Δ0  his3Δ1 ura3Δ0 met15Δ0 --- --- --- --- 
EG81 1 MATa --- his4  ura3  --- lys2 --- --- --- 
112 2 MATα leu2-3-112  his3  ura3-1 --- --- can1-100  ade2-1 --- 
YPH98 3 MATα leu2-∆1 --- ura3-52 --- lys2 801amber --- 
ade2 
101ochre trp1-∆1 
DC5/6 4 MATa/MATα  leu2/leu2 his3/+  his3/+  --- --- --- can1/can1 --- --- 
L5528 5 MATa --- his3:hisG ura3–52 --- --- --- --- --- 
1 [68], 2 [69], 3 [109], 4 [78, 112], 5 [121]  
 
Filamentation was further studied in glucose-starved cells grown in liquid medium 
batch cultures. Identically to what was observed in solid media, none of the strains 
displayed filamentation up to 5 days incubation (Fig. 21). Interestingly, the budding 
pattern of BY4741 wt KRASwt strain was different (Fig. 21 panel G – white arrows). A 
bipolar budding pattern was observed in the vast majority of dividing cells. Although, 
this is usually characteristic of diploid cells [132], it has also been associated with 
haploid invasive growth [136]. Additionally, the bud site selection has been suggested 
not to be a fixed parameter determined by cell type, but rather a dynamic process 
sensitive to environmental cues like nutrient deprivation [132]. According to the 
literature, haploid cells can switch their budding pattern from axial to bipolar and 
consequently form filaments through a series of polarized cell divisions [132], and 
these last should be enough to penetrate agar as was seen in the ras2∆ KRASwt strain 
(Fig. 20). The present results appear to indicate that although the occurrence of the 
budding pattern switching is necessary to find filamentous growth, it might not be 
sufficient. There is the further possibility that a rare event like might have happened, 
like homothallic a/a diploidy [137], or even of an a/α switch allowing mating [138]. 
Importantly, the BY4741 is MATa, but is not deleted for HO, the site-specific 
endonuclease that is required for homothallic switching [139]. Its expression is under 
the control of Swi4p, Swi5p, Swi6p and Ash1p [140]. The Swi4p and 6 proteins work in 
the dependence of the TOR/PKC pathways and act as transcription regulators allowing 
parts of the chromosomes to become available for expression. As mentioned above, 
the crosstalk between TOR, RAS and PKC could lead to miss-regulation of genes 
under their interdependence including HO, and allow mating type switching and the 
consequent diploidization of the culture.  
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Figure 21. Morphological appearance of cells of the BY4741 S. cerevisiae set of strains expressing 
human KRASwt: wt (A); ras1∆ (B); ras2∆ (C); wt p426ø (D); ras1∆ p426ø (E); ras2∆ p426ø (F); wt 
KRASwt (G); ras1∆ KRASwt (H) and ras2∆ KRASwt (I). Cells were starved in YNB w/o glucose for 5 days 
at 30ºC and examined by light microscopy. White arrows in panel G indicate bipolar budding. 
 
Genetically, the processes of cell adhesion, bud site selection and cell 
morphogenesis, which together are required for filament formation in S. cerevisiae, can 
be dissected from each other [141], generating possible discrepant results of adhesion, 
invasion and differentiation. Although the filament formation and invasion depend on 
signalling through elements of the MAP kinase cascade that controls filamentous 
growth, each process is ultimately controlled by distinct downstream morphological 
pathways [132, 142]. Moreover, for cells to be able to invade, they need to adhere to 
the growth medium surface, which nevertheless does not implicate invasion. Actually, 
adhesion, invasion and differentiation are all processes related to haploid invasive 
growth, and the absence of filament structures partially compromises the invasive 
growth [142]. In sum, we can consider that the ras2∆ KRASwt strain from BY4741 
background grown in YNB with glucose demonstrated a haploid invasive growth 
phenotype characterized by non-filamentous growth. Moreover, the putatively 
hyperactivated BY4741 wt KRASwt strain, showed bipolar growth without invasive or 
filamentous growth.  
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3.2.4 Effect of KRASwt expression on chronological life span and 
cell cycle 
In S. cerevisiae growing on glucose-based medium, the activated RAS/cAMP/PKA 
pathway negatively regulates the entry into stationary phase through Ras2 activity 
[143, 144]. Loss of RAS/cAMP/PKA signalling, namely through the deletion of RAS2, 
leads to stationary phase-like growth arrest [143], accompanied by a decreased 
metabolic activity, increased resistance to a variety of environmental stress conditions, 
and an altered pattern of gene expression, essential for the long-term survival of these 
cells [145, 146]. Consequently, the deletion of RAS2 causes the decrease of growth 
rate but the extension of chronological life span [27, 89]. These two processes were 
analysed using all the strains as above. 
 
3.2.4.1 Chronological life span  
Batch cultures on YNB with 2% glucose supplemented with the necessary amino 
acids were followed throughout exponential growth phase by the measuring of the 
optical density at 600nm. The values estimated for the correspondent growth rates 
(Table 5) indicate that all strains grow identically on glucose (mean µg 0.191±0.031 h-1) 
except for ras2∆ KRASwt strain that presented a slower specific growth rate (±60% the 
mean value of the other strains). Additionally, the O.D. achieved at T30h was identical 
for all strains, including the ras2∆ KRASwt (mean O.D. 0.167±0.082), while the wt 
KRASwt presented a long lag phase of ±10h that is not observed in any other strain (not 
shown). All taken, the absence of significant differences in growth on glucose indicate 
identical fitness throughout glucose consumption as expected. Otherwise, the 
chronological life span (CLS) should be affected in view of the involvement of Ras 
proteins in aging [27, 104].  
 
Table 5. Specific growth rates (µg) of S. cerevisiae BY4741 wt, ras1∆ and ras2∆ untransformed, 
harbouring p426ø, and expressing KRASwt strains, grown in YNB medium with 2% glucose. Each value 
is the mean of three independent experiments. 
 
µg (h-1) 
 
Wt ras1∆ ras2∆ 
--- 0,206 ±0.084 0,177 ±0.092 0,182 ±0.094 
p426ø 0,184 ±0.048 0,237 ±0.095 0,165 ±0.089 
KRASwt 0,230 ±0.041 0,158 ±0.091 0,120 ±0.098 
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Cellular viability was assessed by c.f.u assay throughout the stationary phase 
until almost complete death of culture, according to the methodology described in the 
literature [118] (see Materials and Methods). The survival curves (Fig. 22) showed that, 
surprisingly, the expression of the empty p426ø conferred both ras1∆ and ras2∆ an 
extended survival rate compared with wt also expressing the empty plasmid: at day 2, 
they had lost, respectively, approximately 40, 20 and 60% viability. Nevertheless, 
complete death of the culture was several days faster for ras1∆p426ø. These 
differences are not too notorious and require confirmation in the future but suggest that 
the predicted interference of auxotrophic marks in RAS mutants phenotypes might 
actually be true since the empty plasmid is only conferring complementation for uracil. 
Figure 22. Survival of the BY4741 S. cerevisiae set of strains expressing human KRASwt during 
chronological aging phase. Cells were inoculated in YNB w/ 2% glucose and survival was monitored by 
c.f.u. Assays took place after exponential phase ended: T0 corresponds to 100% survival. Results 
correspond to one (preliminary) experience. 
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On the other hand, the expression of KRASwt decreased cell survival of all strains. 
This loss of viability was stronger for ras1KRASwt and ras2∆KRASwt. At day 6, almost 
all of their cultures were death while wtKRASwt still presented almost 20% of the culture 
alive. The results made evident that the ras2∆ KRASwt had a clear more pronounced 
loss of viability than other strains.  
 
3.2.4.2 Cell cycle analysis 
To clarify the effect of KRASwt expression during yeast growth and aging, the cell 
cycle of yeast was evaluated by flow cytometry. The division into different cell cycle 
phases is based on the amount of DNA detected with a specific probe, SYTOX Green. 
Four peaks can be observed: (1) at G1, when the DNA is in single copy; (2) at G2/M, 
when the DNA has already been duplicated but the cell is still not divided; (3) at the S 
phase, when DNA is being duplicated, but the duplication is not complete; and (4) at 
Sub-G0 phase corresponding to fragmented and or condensed DNA. 
Cultures growing exponentially on glucose were used to assess the cell cycle 
progression during the exponential growth/replicative phase (Fig. 23). Identical cultures 
were allowed to grow onto late stationary phase up to 3 and 6 days and were then 
used to analyse the cell cycle during aging (Fig. 24).  
 
 
Figure 23. Cell cycle analysis by flow cytometry of the BY4741 S. cerevisiae set of strains expressing 
human KRASwt. Strains were grown on YNB w/ 2% glucose up to mild-exponential phase. Results 
correspond to one (preliminary) experience. 
Chapter III – Results and Discussion 
 
56 
 
Exponentially growing cells of almost all strains showed an equilibrated subdivision 
of the population between the three main phases of the cell cycle, having the majority 
of cells in G1 or G2/M and a smaller amount in S. The empty plasmid did not cause 
any effect on the distribution of cells through the several DNA replicative cycle of wt or 
ras1∆ cells. Conversely, it appeared to have an effect on ras2∆ strain, which presented 
a high percentage of cells in G0/G1. This should indicate a non-dividing culture, but is 
apparently not compatible with the results of growth above presented (Table 5) that did 
not differ from the other strains. Yet, it cannot be disregarded the possibility that the 
cells in the culture might yield a similar O.D. by having a very different size, therefore 
masking a slow-growing phenotype. The ras2∆ mutant is known to have a large cell 
size, almost doubling the size of wt (Brito A.S. (unpublished results) and [147].  
The expression of KRASwt in the mutants caused an accumulation of cells in 
G0/G1, compared to the respective untransformed strains, while no effect was seen on 
the BY4741 wt KRASwt. These results suggest that the expression of KRASwt in ras1∆ 
causes a delay in the cell cycle that nevertheless does not match this strain growth 
rates (Table 5). On the other hand, the ras2∆ G1/G0 arrest caused by the empty 
plasmid was not significantly changed by the expression of KRASwt. 
 
 
Figure 24. Cell cycle analysis by flow cytometry of the BY4741 S. cerevisiae set of strains expressing 
human KRASwt. Strains were grown on YNB w/ 2% glucose up to late-stationary phase. Results 
correspond to one single (preliminary) experience.  
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Corroborating the absence of effect that the above results suggests identical 
assays after 3 days of incubation - stationary phase - yielded identical results (Fig. 24). 
As expected, all strains had a higher percentage of cells in the G0/G1 phase, indicating 
a proper arrest in G0/G1, which is characteristic of non-dividing and chronological 
aging cells. Further, along the stationary phase, after 6 days, the strains were 
presenting almost all cells in sub-G0 indicating large DNA fragmentation as expected 
according to the loss of viability of the culture above described. Therefore, these results 
show a strong correlation with the faster loss of cell viability verified during yeast 
chronological aging (Fig. 22). 
 
3.2.5 Comments on KRASwt-associated phenotyping  
In the previous studies, the phenotypic complementation of the RAS double mutant, 
which is usually unviable, was achieved with the human HRAS isoform, but not with 
KRAS isoform (in the 112-699 and JR25-3C strains background) [123, 148]. Moreover 
the complementation of the single RAS2 deletion, using the KRASwt isoform was also 
not achieved (in the W303-1B background) [149, 150]. This may be due to the fact that 
the two human isoforms are functionally different [70]. In addition, the correct functional 
expression of a foreign gene in yeast, in particular a human cDNA, requires that a 
complex multi-step process from gene to mature protein [151] occur in the correct 
manner through conserved mechanisms. RAS signalling is a rather conserved pathway 
bearing much in common in several organisms including yeast and -human [108]. 
Therefore, chances are good that KRASwt might work appropriately in yeast. The 
phenotypes detected in this work suggest that the RAS pathway might be 
hyperactivated through the heterologous expression of KRASwt in a wt yeast. 
Otherwise, the complementation of the RAS deletions appears less evident. Finally, it 
is important to advertise that in the literature, to the best of our knowledge, there are no 
works using the EUROSCARF background to the phenotype screening of RAS genes. 
The putative impact of the amino acid metabolic pathways on RAS-associated 
phenotypes is not to be discarded since feedback regulation is known to exist between 
nitrogen sensing, amino acid pathways, TOR and RAS/cAMP/PKA pathways [152, 
153]. 
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4. Final Remarks 
The aim of this thesis was the construction of KRASwt expressing strains of S. 
cerevisiae, and the subsequent phenotype screening, as part of the development of a 
yeast-based phenotypic platform for future pharmacological testing. The heterologous 
expression of KRASwt cDNA was successfully obtained in BY4741 wt and the derived 
ras1∆ and ras2∆ mutants. The presence of the gene was confirmed by PCR of the 
DNA extracted from transformants, and the production of protein was proven by 
Western Blot assay with anti-KRas antibody. These and the correspondent recipient 
strains alone, or harbouring the empty plasmid, constituted a set of strains that were 
used for phenotyping. The cloning procedures were repeated using p426GPD and 
p416GPD but were only successful with the former. The collection of strains obtained 
is: 
 
 BY4741 wt  
 BY4741 wt p426 
 BY4741 wt p426 KRASwt 
 BY4741 ras1∆ 
 BY4741 ras1∆ p426 
 BY4741 ras1∆ p426 KRASwt 
 BY4741 ras2∆ 
 BY4741 ras2∆ p426 
 BY4741 ras2∆ p426 KRASwt 
 
 The second objective of this work was to use this collection of strains to study 
the effect of KRASwt expression, including the verification of the ability of KRASwt to 
complement the deletion of yeast homologue genes. The literature predicts that the 
RAS2 deletion leads to defective growth on non-fermentable carbon sources, and 
impaired invasion capacity, as well as an increase of stress resistance and 
chronological lifespan [27, 80]. The cellular processes assessed took into account the 
literature: growth rate, chronological aging, cell cycle, haploid invasive growth, growth 
on non-fermentable carbon sources, as well as the cell resistance to different stresses 
(high temperature, osmotic stress, low and high pH and oxidative stress). Summarizing 
results: 
 
 KRASwt expression did not affect the resistance that RAS mutants have to high-
temperature (37 ºC), osmotic stress, low and high pH, and oxidative stress 
caused by 1 mM H2O2. KRASwt expression otherwise increased the sensitivity 
to other H2O2 concentration (0.5 mM H2O2), and decreased the stress 
resistance of the wt strain to different stresses except to the pH. 
 All strains adhered to the YNB solid medium with and without glucose, and 
adherence was enhanced by KRASwt expression, while only ras2∆ KRASwt 
Chapter IV – Final Remarks 
 
62 
 
strain was able to invade the medium (YNB with glucose). None of the strains 
presented filamentous growth. 
 Extensive bipolar budding was observed in S. cerevisiae wt KRASwt cells 
growing on YNB liquid medium without glucose. This might derive from a a/α 
switch allowing mating and consequent diploidy.  
 KRASwt decreased chronological life span, namely in ras2∆ strain. 
 All strains presented decreased growth in ethanol and glycerol, intensified with 
the expression of KRASwt, more so in the wt strain.  
 
In the BY4741 yeast genetic background used in this work, the deletion of RAS1 or 
RAS2 had a phenotypic impact much less significant than described in the literature. 
This was surprising but understandable considering that BY4741 and derived strains 
have not been used before to study RAS-associated biological processes. This 
emphasises a recurrent problem, so often observed in the literature, of results’ 
generalization between different in yeast species, which is also important between 
different yeast stains, in particular when these have cumulative numbers of mutations 
affecting metabolism like auxotrophic marks [154]. Accordingly, the functional 
complementation of either ras1∆ or ras2∆ by KRASwt could not be demonstrated in any 
of the phenotypes tested in solid medium assays since the recipient mutant and wt 
strains often behaved identically. This raises considerable questions as to (1) the true 
roles attributed to, and molecular regulation of RAS pathway in yeast, or (2) the 
masking/interfering effect of amino acid metabolic pathways on RAS-derived yeast 
phenotypes. 
Results further showed that the heterologous expression of KRASwt on yeast RAS 
mutants (1) decreased growth on non-fermentable carbon sources, (2) had a negative 
or null effect on the resistance to stress, (3) increased the adhesion capacity, (4) 
stimulated the haploid invasive growth in the ras2∆ strain, and (5) decreased the 
chronological lifespan. Importantly, the expression of KRASwt on the wt strain therefore 
harbouring native RAS1 and RAS2 caused phenotypic changes that could be 
explained by the hyperactivation of the RAS pathway, leading to increased cell 
proliferation and decreased longevity and stress resistance. This result is compatible 
with the notion that the hyperativation of the RAS pathway is typical of cancer cells, 
which present uncontrolled growth [91, 110]. Finally, this wt KRASwt strain also showed 
a bipolar budding pattern that might derive from abnormal diploidy. 
Altogether, the results from the phenotyping assays using the set of strains 
generated within the present thesis open novel routes for investigating the roles of Ras 
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proteins and pathway in yeast. Importantly, on the process of developing a yeast-based 
high throughput platform for pharmacological testing, the hereby-described results will 
be confront with other strains’ phenotyping (a) expressing KRASwt from a chromosomal 
instead of plasmidic construction, and (b) having a different genetic background.  
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